<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T19:58:34Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:4600830" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:4600830</identifier><datestamp>2015-11-02</datestamp><setSpec>frontcellneuro</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Front Cell Neurosci</journal-id>
      <journal-id journal-id-type="iso-abbrev">Front Cell Neurosci</journal-id>
      <journal-id journal-id-type="publisher-id">Front. Cell. Neurosci.</journal-id>
      <journal-title-group>
        <journal-title>Frontiers in Cellular Neuroscience</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1662-5102</issn>
      <publisher>
        <publisher-name>Frontiers Media S.A.</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC4600830</article-id>
      <article-id pub-id-type="pmcid">PMC4600830</article-id>
      <article-id pub-id-type="pmc-uid">4600830</article-id>
      <article-id pub-id-type="pmid">26528127</article-id>
      <article-id pub-id-type="doi">10.3389/fncel.2015.00386</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Neuroscience</subject>
          <subj-group>
            <subject>Original Research</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Regulatory domain or CpG site variation in <italic>SLC12A5</italic>, encoding the chloride transporter KCC2, in human autism and schizophrenia</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Merner</surname>
            <given-names>Nancy D.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/262835/overview"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chandler</surname>
            <given-names>Madison R.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bourassa</surname>
            <given-names>Cynthia</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/259033/overview"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Liang</surname>
            <given-names>Bo</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Khanna</surname>
            <given-names>Arjun R.</given-names>
          </name>
          <xref ref-type="aff" rid="aff4">
            <sup>4</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/86777/overview"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Dion</surname>
            <given-names>Patrick</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rouleau</surname>
            <given-names>Guy A.</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
          <xref ref-type="author-notes" rid="fn001">
            <sup>*</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/5397/overview"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kahle</surname>
            <given-names>Kristopher T.</given-names>
          </name>
          <xref ref-type="aff" rid="aff4">
            <sup>4</sup>
          </xref>
          <xref ref-type="aff" rid="aff5">
            <sup>5</sup>
          </xref>
          <xref ref-type="author-notes" rid="fn001">
            <sup>*</sup>
          </xref>
          <xref ref-type="author-notes" rid="fn002">
            <sup>â </sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/133694/overview"/>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <sup>1</sup>
        <institution>Harrison School of Pharmacy, Department of Drug Discovery and Development, Auburn University</institution>
        <country>Auburn, AL, USA</country>
      </aff>
      <aff id="aff2">
        <sup>2</sup>
        <institution>Department of Neurology and Neurosurgery, Montreal Neurological Hospital and Institute, McGill University</institution>
        <country>MontrÃ©al, QC, Canada</country>
      </aff>
      <aff id="aff3">
        <sup>3</sup>
        <institution>Department of Biological Chemistry and Molecular Pharmacology (BCMP), Harvard Medical School</institution>
        <country>Boston, MA, USA</country>
      </aff>
      <aff id="aff4">
        <sup>4</sup>
        <institution>Department of Neurosurgery, Boston Childrenâs Hospital and Harvard Medical School</institution>
        <country>Boston, MA, USA</country>
      </aff>
      <aff id="aff5">
        <sup>5</sup>
        <institution>Manton Center for Orphan Disease Research, Boston Childrenâs Hospital</institution>
        <country>Boston, MA, USA</country>
      </aff>
      <author-notes>
        <fn fn-type="edited-by">
          <p>Edited by: Ludovic MARTIN, UniversitÃ© de Paris V, France</p>
        </fn>
        <fn fn-type="edited-by">
          <p>Reviewed by: Melanie A Woodin, University of Toronto, Canada; Wen-Jun Gao, Drexel University College of Medicine, USA</p>
        </fn>
        <corresp id="fn001">*Correspondence: Guy A. Rouleau, Department of Neurology and Neurosurgery, Montreal Neurological Hospital and Institute, MontrÃ©al, QC, Canada <email xlink:type="simple">guy.rouleau@mcgill.ca</email>; Kristopher T. Kahle, Department of Neurosurgery, Boston Childrenâs Hospital, Harvard Medical School, 1309 Enders Research Building, 320 Longwood Avenue, Boston, MA 02115, USA <email xlink:type="simple">kkahle@enders.tch.harvard.edu</email></corresp>
        <fn fn-type="other" id="fn002">
          <p><sup>â </sup>Present address: Kristopher T. Kahle, Department of Neurosurgery and Pediatrics, Yale School of Medicine, Yale Program on Neurogenetics, New Haven, CT, USA</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub">
        <day>12</day>
        <month>10</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2015</year>
      </pub-date>
      <volume>9</volume>
      <elocation-id>386</elocation-id>
      <history>
        <date date-type="received">
          <day>12</day>
          <month>7</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>16</day>
          <month>9</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright Â© 2015 Merner, Chandler, Bourassa, Liang, Khanna, Dion, Rouleau and Kahle.</copyright-statement>
        <copyright-year>2015</copyright-year>
        <copyright-holder>Merner, Chandler, Bourassa, Liang, Khanna, Dion, Rouleau and Kahle</copyright-holder>
        <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution and reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Many encoded gene products responsible for neurodevelopmental disorders (NDs) like autism spectrum disorders (ASD), schizophrenia (SCZ), intellectual disability (ID), and idiopathic generalized epilepsy (IGE) converge on networks controlling synaptic function. An increase in KCC2 (<italic>SLC12A5</italic>) Cl<sup>â</sup> transporter activity drives the developmental GABA excitatory-inhibitory sequence, but the role of KCC2 in human NDs is essentially unknown. Here, we report two rare, non-synonymous (NS), functionally-impairing variants in the KCC2 C-terminal regulatory domain (CTRD) in human ASD (R952H and R1049C) and SCZ (R952H) previously linked with IGE and familial febrile seizures, and another novel NS KCC2 variant in ASD (R1048W) with highly-predicted pathogenicity. Exome data from 2517 simplex families in the ASD Simon Simplex Collection (SSC) revealed significantly more KCC2 CTRD variants in ASD cases than controls, and interestingly, these were more often synonymous and predicted to disrupt or introduce a CpG site. Furthermore, full gene analysis showed ASD cases are more likely to contain rare KCC2 variants affecting CpG sites than controls. These data suggest genetically-encoded dysregulation of KCC2-dependent GABA signaling may contribute to multiple human NDs.</p>
      </abstract>
      <kwd-group>
        <kwd>KCC2</kwd>
        <kwd>NKCC1</kwd>
        <kwd>GABA</kwd>
        <kwd>neurodevelopmental disorders</kwd>
        <kwd>autism</kwd>
        <kwd>schizophrenia</kwd>
      </kwd-group>
      <counts>
        <fig-count count="1"/>
        <table-count count="6"/>
        <equation-count count="0"/>
        <ref-count count="92"/>
        <page-count count="10"/>
        <word-count count="8459"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="introduction" id="s1">
      <title>Introduction</title>
      <p>Neurodevelopmental disorders (NDs) encompass a wide range of diseases, all of which feature some element of impaired brain development, and are associated with cognitive, neurological, and/or psychiatric dysfunction (Rubenstein, <xref rid="B77" ref-type="bibr">2011</xref>). Common NDs include intellectual disability (ID), autism spectrum disorder (ASD), schizophrenia (SCZ), and epilepsy (Guilmatre et al., <xref rid="B34" ref-type="bibr">2009</xref>; Bozzi et al., <xref rid="B10" ref-type="bibr">2012</xref>), and although classified into distinct disease categories, these disorders show phenotypic overlap and shared genetic risk factors (Mitchell, <xref rid="B68" ref-type="bibr">2011</xref>; Coe et al., <xref rid="B18" ref-type="bibr">2012</xref>). The genetic architecture of NDs is complex, with oliogenic contributions converging on the disruption of the structure, function, and/or plasticity of neuronal networks (Pescosolido et al., <xref rid="B72" ref-type="bibr">2012</xref>). Genomics has shed insight into mechanisms underlying the overlap among the NDs, with copy number variant, exome sequencing, and genome-wide association study data suggesting a spectrum of neurodevelopmental pathology indexed by mutational load or severity (Krystal and State, <xref rid="B56" ref-type="bibr">2014</xref>). Emerging evidence has shown many of the encoded gene products responsible for individual NDs converge on a relatively limited number of protein-protein interaction networks that operate in the same molecular processes, such as those controlling synaptic structure and function (Gilman et al., <xref rid="B32" ref-type="bibr">2011</xref>; Voineagu et al., <xref rid="B90" ref-type="bibr">2011</xref>; OâRoak et al., <xref rid="B71" ref-type="bibr">2012</xref>; EPGP Collaborative et al., <xref rid="B2" ref-type="bibr">2013</xref>; de Rubeis et al., <xref rid="B24" ref-type="bibr">2014</xref>; Krumm et al., <xref rid="B55" ref-type="bibr">2014</xref>).</p>
      <p>Small, diverse populations of inhibitory GABAergic interneurons regulate the activity of excitatory neurons and their involved circuits. If inhibition is impaired, disturbance in excitatory/inhibitory balance can lead to the dysfunction of cognitive processes (Braat and Kooy, <xref rid="B11" ref-type="bibr">2015</xref>). A common feature among different NDs is impaired GABAergic inhibition (Hashimoto et al., <xref rid="B37" ref-type="bibr">2008</xref>; Kang and Macdonald, <xref rid="B51" ref-type="bibr">2009</xref>; Schmidt and Mirnics, <xref rid="B80" ref-type="bibr">2014</xref>), and neuronal hyperexcitability has been implicated in the pathogenesis of ASD (Coghlan et al., <xref rid="B19" ref-type="bibr">2012</xref>), SCZ (Lewis et al., <xref rid="B62" ref-type="bibr">2012</xref>), Rett syndrome (Medrihan et al., <xref rid="B64" ref-type="bibr">2008</xref>; Chao et al., <xref rid="B16" ref-type="bibr">2010</xref>), Tourette syndrome (Kalanithi et al., <xref rid="B50" ref-type="bibr">2005</xref>), tuberous sclerosis (Talos et al., <xref rid="B83" ref-type="bibr">2012</xref>), and neurofibromatosis type I (Cui et al., <xref rid="B21" ref-type="bibr">2008</xref>). The strong bidirectional association between NDs and epilepsy suggests impaired GABAergic inhibition as a potential pathogenic mechanism of mutual susceptibility (Tuchman and Rapin, <xref rid="B86" ref-type="bibr">2002</xref>; Brooks-Kayal, <xref rid="B12" ref-type="bibr">2010</xref>; Chang et al., <xref rid="B15" ref-type="bibr">2011</xref>; Deidda et al., <xref rid="B25" ref-type="bibr">2014</xref>).</p>
      <p>Ionotropic GABA<sub>A</sub>Rs are ligand-gated Cl<sup>â</sup> channels, and the post-synaptic response to GABA<sub>A</sub>R activation is significantly modulated by the intraneuronal concentration of Cl<sup>â</sup> ([Cl<sup>â</sup>]<sub>i</sub>). In immature neurons, [Cl<sup>â</sup>]<sub>i</sub> is sufficiently high that GABA<sub>A</sub>R activation triggers giant depolarizing potentials, which characterize early network activity and stimulate Ca<sup>2+</sup>-dependent synaptogenesis (Ben-Ari et al., <xref rid="B8" ref-type="bibr">1989</xref>; Belhage et al., <xref rid="B6" ref-type="bibr">1998</xref>). A post-natal increase in the functional expression of KCC2 (<italic>SLC12A5</italic>), a cation-Cl<sup>â</sup> cotransporter (CCC) mediating Cl- efflux, lowers [Cl<sup>â</sup>]<sub>i</sub> in post-synaptic neurons such that GABA<sub>A</sub>R activation elicits membrane hyperpolarization and fast synaptic inhibition (Kaila et al., <xref rid="B49" ref-type="bibr">2014</xref>). KCC2 is required for the normal developmental GABA excitatory-inhibitory sequence, and KCC2 deficiency disrupts normal brain development and results in network hyperexcitability (Hubner et al., <xref rid="B42" ref-type="bibr">2001</xref>; Hekmat-Scafe et al., <xref rid="B40" ref-type="bibr">2006</xref>, <xref rid="B41" ref-type="bibr">2010</xref>; Tanis et al., <xref rid="B84" ref-type="bibr">2009</xref>; Bellemer et al., <xref rid="B7" ref-type="bibr">2011</xref>).</p>
      <p>Abnormal functional expression of KCC2 or its Cl<sup>â</sup> importing cousin NKCC1, and associated impairment of GABA inhibition, have been documented in rodent models of multiple different NDs [see Table 1 in Deidda et al. (<xref rid="B25" ref-type="bibr">2014</xref>)]. For example, in mouse models of Fragile X syndrome, the most common genetic cause of human autism, there is a significantly delayed developmental switch to GABAergic inhibition due to prolonged elevation in neuronal [Cl<sup>â</sup>]<sub>i</sub> due in part to decreased KCC2 expression (Lemonnier et al., <xref rid="B61" ref-type="bibr">2013</xref>), and blockade of up-regulated NKCC1-mediated Cl<sup>â</sup> import in this context normalizes [Cl<sup>â</sup>]<sub>i</sub>, electrophysiological responses, and autistic-like behaviors in these mice (Tyzio et al., <xref rid="B87" ref-type="bibr">2014</xref>), and improves autistic behaviors in humans (Lemonnier et al., <xref rid="B60" ref-type="bibr">2012</xref>). However, the role of KCC2 in the human nervous system and in NDs is essentially unknown. Identification of such variants could elucidate the molecular pathophysiology of these diseases and identify therapeutic targets.</p>
      <p>The KCC2 C-terminal regulatory domain (CTRD) is a critical region of transporter function, and contains multiple phosphorylated residues (such as Thr906/Thr1007 and Ser940 (reviewed in Blaesse et al., <xref rid="B9" ref-type="bibr">2009</xref>; Chamma et al., <xref rid="B14" ref-type="bibr">2012</xref>; Kahle et al., <xref rid="B47" ref-type="bibr">2013</xref>; Medina et al., <xref rid="B63" ref-type="bibr">2014</xref>); and functional domains (e.g., Acton et al., <xref rid="B3" ref-type="bibr">2012</xref>) that establish context-appropriate transport activity (de Los Heros et al., <xref rid="B23" ref-type="bibr">2014</xref>; see Figure <xref ref-type="fig" rid="F1">1</xref>). We recently identified an enrichment of KCC2 non-synonymous (NS) alleles in French Canadian (FC) idiopathic generalized epilepsy (IGE) cases compared to controls that included two rare and functional IGE risk alleles (KCC2 R952H and R1049C; Kahle et al., <xref rid="B48" ref-type="bibr">2014</xref>). Both of these variants decrease KCC2-mediated Cl<sup>â</sup> extrusion and render neuronal GABA activity more depolarized by decreasing the amount of Ser940 stimulatory phosphorylation (Kahle et al., <xref rid="B48" ref-type="bibr">2014</xref>). KCC2 R952H was also identified as a cause of an inherited form of febrile seizures in an Australian family, and shown to impair dendritic spine formation (Puskarjov et al., <xref rid="B75" ref-type="bibr">2014</xref>).</p>
      <fig id="F1" position="float">
        <label>Figure 1</label>
        <caption>
          <p><bold><italic>KCC2</italic> (<italic>SLC12A5</italic>) variants in human autism spectrum disorder (ASD) and schizophrenia (SCZ). (A)</bold> DNA chromatograms illustrating the detection of KCC2 variants in ASD (c.2855 G &gt; A [p.R952H]; c.3145 C &gt; T [p.R1049C]; and c.3142 C &gt; T [p.R1048W]); and SCZ (p.R952H) via Sanger sequencing. <bold>(B,C)</bold> Evolutionary conservation of amino acid p.R1048; and conservation of amino acids p.R952 and p.R1049 shown in Kahle et al. (<xref rid="B48" ref-type="bibr">2014</xref>). <bold>(D)</bold> Schematic representation of KCC2 (human). Orange dots indicate the positions of the known critical phospho-regulatory residues p.T906, p.S940, p.T1007, and p.Y1087 (reviewed in Chamma et al., <xref rid="B14" ref-type="bibr">2012</xref>; Kahle et al., <xref rid="B47" ref-type="bibr">2013</xref>); Pink region denotes the KCC2 âISOâ domain, required for hyperpolarizing GABAergic transmission (Acton et al., <xref rid="B3" ref-type="bibr">2012</xref>). Red dots depict the identified IGE mutations, p.R952 and p.R1049; green dots depict the identified ASD variants, p.R952H, p.R1049C, and p.R1048W; yellow dots indicate the identified SCZ variant p.R952H. <bold>(E)</bold> The modeled structure of the human KCC2 C-terminal domain (CTRD), based on homology modeling by I-TASSER (Roy et al., <xref rid="B76" ref-type="bibr">2010</xref>) using a prokaryotic member of the CCC family (PDB code 3g40) (for details, see âMaterials and Methodsâ Section). Color scheme same as in <bold>(D)</bold>. Note the proximity of the novel p.R1048W ASD variant and the previously described KCC2 IGE variants, as well as their relation to important regulatory residues and domains. <bold>(F)</bold> Venn diagram showing overlap of KCC2 variants in multiple neurodevelopmental phenotypes (IGE, ASD, and SCZ) that exhibit dysfunctional GABA signaling (Deidda et al., <xref rid="B25" ref-type="bibr">2014</xref>).</p>
        </caption>
        <graphic xlink:href="fncel-09-00386-g0001"/>
      </fig>
      <p>Here, we sought to determine if risk alleles in the KCC2 CTRD (amino acids 894â1086; NP_065759) were present in large FC cohorts of ASD, SCZ, or ID by utilizing a similar targeted genetic sequencing approach we successfully utilized for IGE (Kahle et al., <xref rid="B48" ref-type="bibr">2014</xref>). We speculated that genetic mutations and/or functionally impairing variants in the KCC2 CTRD might contribute to NDs.</p>
    </sec>
    <sec sec-type="materials|methods" id="s2">
      <title>Materials and Methods</title>
      <sec id="s2-1">
        <title>Clinical Sampling</title>
        <p>The three disease cohorts of ASD, SCZ, and ID, were established as a part of the Synapse to Disease (S2D) project initiated by Dr. Guy Rouleau at Montreal Neurological Institute and McGill University in order to identify genes that cause or predispose to numerous disorders of brain development. The sample characteristics of these FC cohorts have previously been described (Gauthier et al., <xref rid="B30" ref-type="bibr">2005</xref>; Hamdan et al., <xref rid="B36" ref-type="bibr">2009</xref>; Awadalla et al., <xref rid="B5" ref-type="bibr">2010</xref>).</p>
      </sec>
      <sec id="s2-2">
        <title>KCC2 C-Terminus Targeted Screening</title>
        <p>We implemented a targeted DNA Sanger sequencing approach to screen the 3â² end of <italic>SLC12A5</italic> that encodes the CTRD of KCC2 (Kahle et al., <xref rid="B48" ref-type="bibr">2014</xref>). Specifically, we targeted the coding nucleotides in exons 21â25 of <italic>SLC12A5</italic> [NM_020708.4 (NP_065759 amino acids 894â1086) or NM_001134771 (NP_001128243 amino acids 917â1110)] by following the same protocol outlined in Kahle et al. (<xref rid="B48" ref-type="bibr">2014</xref>); a total of 427 ASD, 143 SCZ and 190 ID cases were screened. A total of 1214 matched controls were previously screened for mutations in the targeted region of KCC2 (Kahle et al., <xref rid="B48" ref-type="bibr">2014</xref>).</p>
      </sec>
      <sec id="s2-3">
        <title>Protein Sequence Alignment and <italic>In Silico</italic> Prediction Programs</title>
        <p>ClustalW (Larkin et al., <xref rid="B59" ref-type="bibr">2007</xref>) and WebLogo (Crooks et al., <xref rid="B20" ref-type="bibr">2004</xref>) were used to align different orthologues of the KCC2 to determine the evolutionary conservation of the novel KCC2 variant, R1048W (Figures <xref ref-type="fig" rid="F1">1B,C</xref>). Conservation of KCC2 R952H and R1049C were previously demonstrated (Kahle et al., <xref rid="B48" ref-type="bibr">2014</xref>). Conservation of the KCC2 protein was determined by aligning the following orthologues: <italic>Homo sapiens</italic> (NP_065759), <italic>Macaca mulatta</italic> (XM_001104494.2_prot), <italic>Bos Taurus</italic> (NP_001193309), <italic>Rattus norvegicus</italic> (NP_599190), <italic>Mus musculus</italic> (NP_065066), <italic>Tetraodon nigroviridis</italic> (ENSTNIT00000021299), and <italic>Danio rerio</italic> (ENSDART00000009569). Regarding the WebLogo output, the y-axis serves as a means of determining relative conservation and is not an actual measurement; the height of each stack at each amino acid position is relative to the overall conservation at that position, the height of the letters within each stack indicate the relative frequencies for each amino acid possibility, and the width of each stack corresponds to the proportion of valid readings at that position (indicating if sequence gaps exist between the shown amino acids). The effects of amino acid substitutions on protein function were predicted using MutationTaster (Schwarz et al., <xref rid="B81" ref-type="bibr">2010</xref>), Panther (Mi et al., <xref rid="B67" ref-type="bibr">2005</xref>), and Polyphen-2 (Adzhubei et al., <xref rid="B4" ref-type="bibr">2010</xref>).</p>
      </sec>
      <sec id="s2-4">
        <title>Exome Sequencing Analysis</title>
        <p>Iossifov et al. (<xref rid="B44" ref-type="bibr">2014</xref>) recently reported the whole exome sequencing of 2517 ASD simplex families from the Simon Simplex Collection (SSC; Fischbach and Lord, <xref rid="B28" ref-type="bibr">2010</xref>). They carried out a <italic>de novo</italic> mutation analysis that generated an extensive list of <italic>de novo</italic> variants and recurrently hit genes that could be subdivided with different clinical phenotypes (Iossifov et al., <xref rid="B44" ref-type="bibr">2014</xref>). These exome sequencing data are now available through the NDAR (National Database of Autism Research); we were granted access to variant calling files to further assess <italic>SLC12A5</italic>.</p>
        <p>Our analysis involved filtering for sample type to include only probands (.p1), accession number (NM_001134771) to include only <italic>SLC12A5</italic>, and â_par-races_â (we either selected âwhite, whiteâ or âafrican-amer, african-amerâ) to include probands with either two Caucasian parents (EA ASD cases) or two African American parents (AA ASD cases), respectively. According to Supplementary Table 1 in Iossifov et al. (<xref rid="B44" ref-type="bibr">2014</xref>), there were 1892 EA ASD cases and 82 AA ASD cases. We carried out a rare variant (&lt;1% MAF) analysis; therefore, we filtered out SNPs (single nucleotide polymorphisms) with a MAF &gt;1% in each ethnic group. This resulted in a list of rare coding variants for the full gene and our targeted gene region. Furthermore, we used the EA and AA Exome Variant Server (EVS) data (NHLBI GO Exome Sequencing Project)<xref ref-type="fn" rid="fn0001"><sup>1</sup></xref> as our ethnic controls; there were a total of 4300 EA controls and 2203 AA controls exome sequenced. We generated lists of rare variants that were detected in each control cohort.</p>
        <table-wrap id="T1" position="float">
          <label>Table 1</label>
          <caption>
            <p><italic>SLC12A5</italic>
<bold>variants detected in the FC ASD cohort through the targeted screening of the C-terminus</bold>.</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th align="center" colspan="3" rowspan="1">Variants detected in the screened region</th>
                <th align="center" colspan="3" rowspan="1">Detection of variants in Quebec ASD cohort</th>
                <th align="center" colspan="4" rowspan="1">FC population controls (Total: 1214 controls)</th>
              </tr>
              <tr>
                <th align="center" rowspan="1" colspan="1">NM_020708.4 NP_065759</th>
                <th align="center" rowspan="1" colspan="1">NM_001134771.1 NP_001128243</th>
                <th align="center" rowspan="1" colspan="1">rs ID</th>
                <th align="center" rowspan="1" colspan="1">Number of probands</th>
                <th align="center" rowspan="1" colspan="1">Number of alleles</th>
                <th align="center" rowspan="1" colspan="1">Allele frequency (%)</th>
                <th align="center" rowspan="1" colspan="1">Number of alleles</th>
                <th align="center" rowspan="1" colspan="1">Allele frequency (%)</th>
                <th align="center" rowspan="1" colspan="1"><italic>p</italic>-value</th>
                <th align="center" rowspan="1" colspan="1">Odds ratio</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" rowspan="1" colspan="1">c.2855 G &gt; A</td>
                <td align="center" rowspan="1" colspan="1">c.2924 G &gt; A</td>
                <td align="center" rowspan="1" colspan="1">rs142740233</td>
                <td align="center" rowspan="1" colspan="1">2/427</td>
                <td align="center" rowspan="1" colspan="1">2/854</td>
                <td align="center" rowspan="1" colspan="1">0.23</td>
                <td align="center" rowspan="1" colspan="1">5/2428</td>
                <td align="center" rowspan="1" colspan="1">0.21</td>
                <td align="center" rowspan="1" colspan="1">1.00</td>
                <td align="center" rowspan="1" colspan="1">1.14</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">p.R952H</td>
                <td align="center" rowspan="1" colspan="1">p.R975H</td>
                <td align="left" colspan="7" rowspan="1"/>
                <td align="center" rowspan="1" colspan="1">CI<sub>95</sub>[0.1â7.0]</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">c.2961 G &gt; A</td>
                <td align="center" rowspan="1" colspan="1">c.3030 G &gt; A</td>
                <td align="center" rowspan="1" colspan="1">rs550491448</td>
                <td align="center" rowspan="1" colspan="1">1/427</td>
                <td align="center" rowspan="1" colspan="1">1/854</td>
                <td align="center" rowspan="1" colspan="1">0.12</td>
                <td align="center" rowspan="1" colspan="1">0/2428</td>
                <td align="center" rowspan="1" colspan="1">0.00</td>
                <td align="center" rowspan="1" colspan="1">0.26</td>
                <td align="center" rowspan="1" colspan="1">Inf</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">p.P987P</td>
                <td align="center" rowspan="1" colspan="1">p.P1010P</td>
                <td align="left" colspan="7" rowspan="1"/>
                <td align="center" rowspan="1" colspan="1">CI<sub>95</sub>[0.1-Inf]</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">c.3142 C &gt; T</td>
                <td align="center" rowspan="1" colspan="1">c.3211C &gt; T</td>
                <td align="center" rowspan="1" colspan="1">rs369042030</td>
                <td align="center" rowspan="1" colspan="1">1/427</td>
                <td align="center" rowspan="1" colspan="1">1/854</td>
                <td align="center" rowspan="1" colspan="1">0.12</td>
                <td align="center" rowspan="1" colspan="1">0/2428</td>
                <td align="center" rowspan="1" colspan="1">0.00</td>
                <td align="center" rowspan="1" colspan="1">0.26</td>
                <td align="center" rowspan="1" colspan="1">Inf</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">p.R1048W</td>
                <td align="center" rowspan="1" colspan="1">p.R1071W</td>
                <td align="left" colspan="7" rowspan="1"/>
                <td align="center" rowspan="1" colspan="1">CI<sub>95</sub>[0.1-Inf]</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">c.3145 C &gt; T</td>
                <td align="center" rowspan="1" colspan="1">c.3214 C &gt; T</td>
                <td align="center" rowspan="1" colspan="1">â</td>
                <td align="center" rowspan="1" colspan="1">1/427</td>
                <td align="center" rowspan="1" colspan="1">1/854</td>
                <td align="center" rowspan="1" colspan="1">0.12</td>
                <td align="center" rowspan="1" colspan="1">1/2428</td>
                <td align="center" rowspan="1" colspan="1">4.12 Ã 10<sup>â4</sup></td>
                <td align="center" rowspan="1" colspan="1">0.45</td>
                <td align="center" rowspan="1" colspan="1">2.84</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">p.R1049C</td>
                <td align="center" rowspan="1" colspan="1">p.R1072C</td>
                <td align="left" colspan="7" rowspan="1"/>
                <td align="center" rowspan="1" colspan="1">CI<sub>95</sub>[0.0â223.0]</td>
              </tr>
              <tr>
                <td align="left" colspan="2" rowspan="1">Total number of variants detected</td>
                <td rowspan="1" colspan="1"/>
                <td align="center" rowspan="1" colspan="1">5</td>
                <td align="center" rowspan="1" colspan="1">5</td>
                <td align="center" rowspan="1" colspan="1">â</td>
                <td align="center" rowspan="1" colspan="1">6</td>
                <td align="center" rowspan="1" colspan="1">â</td>
                <td align="center" rowspan="1" colspan="1">0.17</td>
                <td align="center" rowspan="1" colspan="1">2.37</td>
              </tr>
              <tr>
                <td align="left" colspan="9" rowspan="1"/>
                <td align="center" rowspan="1" colspan="1">CI<sub>95</sub>[0.6â9.4]</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
      </sec>
      <sec id="s2-5">
        <title>Statistical Analysis</title>
        <p>All statistical genetic analysis was carried out using the program R (version 2.15.1). Fisher tests or Mantel-Haenzel Chi Squared tests were carried out to generate the <italic>p</italic>-values and odds ratios where appropriate.</p>
      </sec>
    </sec>
    <sec sec-type="results" id="s3">
      <title>Results</title>
      <p>Using Sanger sequencing, we examined the 3â² end of <italic>SLC12A5</italic> that encodes the KCC2 CTRD (amino acids 894â1086; NP_065759) in three large FC disease cohorts of ASD, SCZ, or ID that were collected as part of the S2D project (see âMaterials and Methodsâ Section). In contrast to our previous analysis in IGE which identified an enrichment of KCC2 NS CTRD alleles in IGE cases compared to controls (<italic>p-value</italic> = 7.50 Ã 10<sup>â3</sup>; Kahle et al., <xref rid="B48" ref-type="bibr">2014</xref>), analysis of our initial ASD, SCZ or ID sequencing results did not show an enrichment of NS KCC2 CTRD alleles in cases (Table <xref ref-type="table" rid="T1">1</xref>). Interestingly, however, three different heterozygous and NS KCC2 variants were detected in the ASD cohort; these included the two previously-identified IGE risk variants, R952H and R1049C (Kahle et al., <xref rid="B48" ref-type="bibr">2014</xref>), and R1048W (Figure <xref ref-type="fig" rid="F1">1</xref> and Table <xref ref-type="table" rid="T1">1</xref>).</p>
      <p>R1048 in KCC2 is a highly conserved residue (Figure <xref ref-type="fig" rid="F1">1</xref>), and a substitution for a tryptophan at this position is predicted to be highly pathogenic using multiple <italic>in silico</italic> bioinformatics programs (Table <xref ref-type="table" rid="T2">2</xref>). This variant is extremely rare; it was not detected in 2428 FC alleles, but this number of controls was too small to generate a significant <italic>p</italic>-value (Table <xref ref-type="table" rid="T1">1</xref>). Indeed, power analysis determined that 50,000 control alleles would need to be genotyped, assuming the allele frequencies remain the same and a <italic>p</italic>-value of 0.0167 is significant (after a Bonferroni correction). This limitation is common when identifying rare genetic risk factors, and also relevant for the R1049C variant (Table <xref ref-type="table" rid="T1">1</xref>), where 100,000 control alleles would need to be genotyped to reach significance. R952H was previously determined to have an allele frequency of 0.66% in the FC IGE cohort (Kahle et al., <xref rid="B48" ref-type="bibr">2014</xref>) compared to 0.21% in FC controls and 0.23% in the FC ASD cohort (Table <xref ref-type="table" rid="T1">1</xref>). One SCZ patient was also determined to carry R925H, corresponding to an allele frequency of 0.35% (Table <xref ref-type="table" rid="T3">3</xref>). Two heterozygous synonymous variants were also detected in our screening, including P987P in an ASD patient (Table <xref ref-type="table" rid="T1">1</xref>), and D935D in an SCZ patient (Table <xref ref-type="table" rid="T3">3</xref>).</p>
      <table-wrap id="T2" position="float">
        <label>Table 2</label>
        <caption>
          <p><bold>Predicted pathogenicity of the novel KCC2 (<italic>SLC12A5</italic>) variant</bold>.</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th align="center" colspan="2" rowspan="1">Variant name</th>
              <th align="center" colspan="4" rowspan="1">Prediction programs</th>
            </tr>
            <tr>
              <th align="left" rowspan="1" colspan="1">NM_020708.4 NP_065759</th>
              <th align="center" rowspan="1" colspan="1">NM_001134771.1 NP_001128243</th>
              <th align="center" colspan="2" rowspan="1">Mutation taster</th>
              <th align="center" rowspan="1" colspan="1">Panther</th>
              <th align="center" rowspan="1" colspan="1">Polyphen</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" rowspan="1" colspan="1">c.3142 C &gt; T</td>
              <td align="center" rowspan="1" colspan="1">c.3211C &gt; T</td>
              <td align="center" rowspan="1" colspan="1">Disease</td>
              <td align="center" rowspan="1" colspan="1">P (probability):</td>
              <td align="center" rowspan="1" colspan="1">P<sub>deleterious</sub> = 0.80942</td>
              <td align="center" rowspan="1" colspan="1">Possibly damaging</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">p.R1048W</td>
              <td align="center" rowspan="1" colspan="1">p.R1071W</td>
              <td align="center" rowspan="1" colspan="1">causing*</td>
              <td align="center" rowspan="1" colspan="1">0.9999</td>
              <td rowspan="1" colspan="1"/>
              <td align="center" rowspan="1" colspan="1">(0.813)</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <p><italic>*Predicted specifically to disrupt the function of the last cytoplasmic domain</italic>.</p>
        </table-wrap-foot>
      </table-wrap>
      <table-wrap id="T3" position="float">
        <label>Table 3</label>
        <caption>
          <p><italic>SLC12A5</italic><bold> variants detected in the SCZ cohort through the targeted screening of the C-terminus</bold>.</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th align="center" colspan="3" rowspan="1">Variants detected in the screened region</th>
              <th align="center" colspan="3" rowspan="1">Detection of variants in SCZ cohort</th>
              <th align="center" colspan="4" rowspan="1">FC population controls (Total: 1214 controls)</th>
            </tr>
            <tr>
              <th align="left" rowspan="1" colspan="1">NM_020708.4 NP_065759</th>
              <th align="left" rowspan="1" colspan="1">NM_001134771.1 NP_001128243</th>
              <th align="center" rowspan="1" colspan="1">rs ID</th>
              <th align="center" rowspan="1" colspan="1">Number of probands</th>
              <th align="center" rowspan="1" colspan="1">Number of alleles</th>
              <th align="center" rowspan="1" colspan="1">Allele frequency (%)</th>
              <th align="center" rowspan="1" colspan="1">Number of alleles</th>
              <th align="center" rowspan="1" colspan="1">Allele frequency (%)</th>
              <th align="center" rowspan="1" colspan="1"><italic>p</italic>-value</th>
              <th align="center" rowspan="1" colspan="1">Odds ratio</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" rowspan="1" colspan="1">c.2805 T &gt; C</td>
              <td align="left" rowspan="1" colspan="1">c.2874 T &gt; C</td>
              <td align="center" rowspan="1" colspan="1">rs151293924</td>
              <td align="center" rowspan="1" colspan="1">1/143</td>
              <td align="center" rowspan="1" colspan="1">1/286</td>
              <td align="center" rowspan="1" colspan="1">0.35</td>
              <td align="center" rowspan="1" colspan="1">0/2428</td>
              <td align="center" rowspan="1" colspan="1">0.00</td>
              <td align="center" rowspan="1" colspan="1">0.11</td>
              <td align="center" rowspan="1" colspan="1">Inf</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">p.D935D</td>
              <td align="left" rowspan="1" colspan="1">p.D958D</td>
              <td align="center" colspan="7" rowspan="1"/>
              <td align="center" rowspan="1" colspan="1">CI<sub>95</sub>[0.2-Inf]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">c.2855 G &gt; A</td>
              <td align="left" rowspan="1" colspan="1">c.2924 G &gt; A</td>
              <td align="center" rowspan="1" colspan="1">rs142740233</td>
              <td align="center" rowspan="1" colspan="1">1/143</td>
              <td align="center" rowspan="1" colspan="1">1/286</td>
              <td align="center" rowspan="1" colspan="1">0.35</td>
              <td align="center" rowspan="1" colspan="1">5/2428</td>
              <td align="center" rowspan="1" colspan="1">0.21</td>
              <td align="center" rowspan="1" colspan="1">0.50</td>
              <td align="center" rowspan="1" colspan="1">1.70</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">p.R952H</td>
              <td align="left" rowspan="1" colspan="1">p.R975H</td>
              <td align="center" colspan="7" rowspan="1"/>
              <td align="center" rowspan="1" colspan="1">CI<sub>95</sub>[0.0â15.3]</td>
            </tr>
            <tr>
              <td align="left" colspan="2" rowspan="1">Total number of variants detected</td>
              <td rowspan="1" colspan="1"/>
              <td align="center" rowspan="1" colspan="1">2</td>
              <td align="center" rowspan="1" colspan="1">2</td>
              <td align="center" rowspan="1" colspan="1">â</td>
              <td align="center" rowspan="1" colspan="1">6*</td>
              <td align="center" rowspan="1" colspan="1">â</td>
              <td align="center" rowspan="1" colspan="1">0.20</td>
              <td align="center" rowspan="1" colspan="1">2.85</td>
            </tr>
            <tr>
              <td align="center" colspan="9" rowspan="1"/>
              <td align="center" rowspan="1" colspan="1">CI<sub>95</sub>[0.3â16.1]</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <p><italic>*A total of 6 variants were detected in FC control cohort [5 R975H and 1 R1072C (which is not shown in this table)]</italic>.</p>
        </table-wrap-foot>
      </table-wrap>
      <p>From a functional standpoint, both R952H and R1049C impair KCC2 transporter activity (Kahle et al., <xref rid="B48" ref-type="bibr">2014</xref>); they significantly decrease KCC2-mediated Cl<sup>â</sup> extrusion capacity in neurons, render EGly less hyperpolarized compared to WT KCC2, decrease the level of stimulatory phosphorylation of Ser940, act in a dominant-negative manner consistent with the known oligomerization of KCC2 molecules, and decrease transporter plasmalemmal expression (R952H) or lower the intrinsic activity of transporters at the cell surface (R1049C) (Kahle et al., <xref rid="B48" ref-type="bibr">2014</xref>). We anticipate these variants function similarly in ASD; however, the phenotypic outcomes of any effect of these variants are likely dependent on the combination of other risk alleles within each individual patient. Considering the proximity of R1048 to R1049, and the fact that both variants substitute an arginine, we assume the functional effects of R1048W on KCC2 would be similar to that of R1049C (Kahle et al., <xref rid="B48" ref-type="bibr">2014</xref>).</p>
      <p>Overall, the data generated from the targeted screening of 3â² end of <italic>SLC12A5</italic> in FC cases and controls did not reach statistical significance, possibly due to the rare nature of the variants and the size of the FC cohorts (Table <xref ref-type="table" rid="T4">4</xref>). However, when the SSC and EVS exome sequencing data was considered, the combined analysis indicated there was an enrichment of all coding KCC2 CTRD variants in ASD cases compared to controls (<italic>p-value</italic> = 0.03; Table <xref ref-type="table" rid="T4">4</xref>). In fact, when subdividing the variants into various groups, we determined that ASD cases actually had significantly more synonymous variants compared to controls (<italic>p-value</italic> = 0.02), as well as variants that either disrupted or introduced a CpG site (<italic>p-value</italic> = 6.8 Ã 10<sup>â3</sup>; Table <xref ref-type="table" rid="T4">4</xref>). Upon full gene analysis (using solely exome sequencing data), ASD cases were determined to have a higher percentage of rare <italic>SLC12A5</italic> variants that affect a CpG site compared to controls (Tables <xref ref-type="table" rid="T5">5</xref>, <xref ref-type="table" rid="T6">6</xref>), suggesting a possible epigenetic effect on gene expression through variation in methylation patterns.</p>
      <table-wrap id="T4" position="float">
        <label>Table 4</label>
        <caption>
          <p><bold><italic>SLC12A5</italic> variants detected in the FC and SSC EA and AA cohorts in the targeted region of the C-terminus</bold>.</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th rowspan="1" colspan="1"/>
              <th align="center" colspan="3" rowspan="1">Cohort</th>
              <th align="center" colspan="3" rowspan="1"/>
              <th align="center" colspan="2" rowspan="1">Combined</th>
            </tr>
            <tr>
              <th align="left" rowspan="1" colspan="1">Variant type</th>
              <th align="left" rowspan="1" colspan="1">Ethnicity</th>
              <th align="left" rowspan="1" colspan="1">Group</th>
              <th align="center" rowspan="1" colspan="1">Size</th>
              <th align="center" rowspan="1" colspan="1">Number of rare variants transported</th>
              <th align="center" rowspan="1" colspan="1"><italic>p</italic> value</th>
              <th align="center" rowspan="1" colspan="1">Odds ratio</th>
              <th align="center" rowspan="1" colspan="1"><italic>p</italic> value</th>
              <th align="center" rowspan="1" colspan="1">Odds ratio</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" rowspan="1" colspan="1">All</td>
              <td align="left" rowspan="1" colspan="1">FC</td>
              <td align="left" rowspan="1" colspan="1">ASD Cases</td>
              <td align="center" rowspan="1" colspan="1">427</td>
              <td align="center" rowspan="1" colspan="1">5</td>
              <td align="center" rowspan="1" colspan="1">0.17</td>
              <td align="center" rowspan="1" colspan="1">2.37 CI<sub>95</sub>[0.6â9.4]</td>
              <td align="center" rowspan="1" colspan="1">0.03</td>
              <td align="center" rowspan="1" colspan="1">2.00 CI<sub>95</sub>[1.1â3.6]</td>
            </tr>
            <tr>
              <td align="center" colspan="2" rowspan="1"/>
              <td align="left" rowspan="1" colspan="1">Controls</td>
              <td align="center" rowspan="1" colspan="1">1214</td>
              <td align="center" rowspan="1" colspan="1">6</td>
              <td align="center" colspan="4" rowspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">EA</td>
              <td align="left" rowspan="1" colspan="1">ASD Cases</td>
              <td align="center" rowspan="1" colspan="1">1892</td>
              <td align="center" rowspan="1" colspan="1">12</td>
              <td align="center" rowspan="1" colspan="1">0.09</td>
              <td align="center" rowspan="1" colspan="1">1.95 CI<sub>95</sub>[0.8â4.5]</td>
            </tr>
            <tr>
              <td align="center" colspan="2" rowspan="1"/>
              <td align="center" rowspan="1" colspan="1">EVS Controls</td>
              <td align="center" rowspan="1" colspan="1">4300</td>
              <td align="center" rowspan="1" colspan="1">14</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">AA</td>
              <td align="left" rowspan="1" colspan="1">ASD Cases</td>
              <td align="center" rowspan="1" colspan="1">82</td>
              <td align="center" rowspan="1" colspan="1">2</td>
              <td align="center" rowspan="1" colspan="1">0.35</td>
              <td align="center" rowspan="1" colspan="1">1.67 CI<sub>95</sub>[0.2â6.8]</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td align="center" rowspan="1" colspan="1">EVS Controls</td>
              <td align="center" rowspan="1" colspan="1">2203</td>
              <td align="center" rowspan="1" colspan="1">32</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Non-synonymous</td>
              <td align="left" rowspan="1" colspan="1">FC</td>
              <td align="left" rowspan="1" colspan="1">ASD Cases</td>
              <td align="center" rowspan="1" colspan="1">427</td>
              <td align="center" rowspan="1" colspan="1">4</td>
              <td align="center" rowspan="1" colspan="1">0.30</td>
              <td align="center" rowspan="1" colspan="1">1.90 CI<sub>95</sub>[0.4â8.0]</td>
              <td align="center" rowspan="1" colspan="1">0.31</td>
              <td align="center" rowspan="1" colspan="1">1.53 CI<sub>95</sub>[0.8â3.1]</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Controls</td>
              <td align="center" rowspan="1" colspan="1">1214</td>
              <td align="center" rowspan="1" colspan="1">6</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">EA</td>
              <td align="left" rowspan="1" colspan="1">ASD Cases</td>
              <td align="center" rowspan="1" colspan="1">1892</td>
              <td align="center" rowspan="1" colspan="1">9</td>
              <td align="center" rowspan="1" colspan="1">0.37</td>
              <td align="center" rowspan="1" colspan="1">1.46 CI<sub>95</sub>[0.6â3.6]</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td align="center" rowspan="1" colspan="1">EVS Controls</td>
              <td align="center" rowspan="1" colspan="1">4300</td>
              <td align="center" rowspan="1" colspan="1">14</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">AA</td>
              <td align="left" rowspan="1" colspan="1">ASD Cases</td>
              <td align="center" rowspan="1" colspan="1">82</td>
              <td align="center" rowspan="1" colspan="1">0</td>
              <td align="center" rowspan="1" colspan="1">1.00</td>
              <td align="center" rowspan="1" colspan="1">0.00 CI<sub>95</sub>[0.0â29.7]</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td align="center" rowspan="1" colspan="1">EVS Controls</td>
              <td align="center" rowspan="1" colspan="1">2203</td>
              <td align="center" rowspan="1" colspan="1">5</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Synonymous</td>
              <td align="left" rowspan="1" colspan="1">FC</td>
              <td align="left" rowspan="1" colspan="1">ASD Cases</td>
              <td align="center" rowspan="1" colspan="1">427</td>
              <td align="center" rowspan="1" colspan="1">1</td>
              <td align="center" rowspan="1" colspan="1">0.26</td>
              <td align="center" rowspan="1" colspan="1">Inf CI<sub>95</sub>[0.1-Inf]</td>
              <td align="center" rowspan="1" colspan="1">0.02</td>
              <td align="center" rowspan="1" colspan="1">4.93 CI<sub>95</sub>[1.7â14.8]</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Controls</td>
              <td align="center" rowspan="1" colspan="1">1214</td>
              <td align="center" rowspan="1" colspan="1">0</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">EA</td>
              <td align="left" rowspan="1" colspan="1">ASD Cases</td>
              <td align="center" rowspan="1" colspan="1">1892</td>
              <td align="center" rowspan="1" colspan="1">3</td>
              <td align="center" rowspan="1" colspan="1">0.02</td>
              <td align="center" rowspan="1" colspan="1">Inf CI<sub>95</sub>[0.9-Inf]</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td align="center" rowspan="1" colspan="1">EVS Controls</td>
              <td align="center" rowspan="1" colspan="1">4300</td>
              <td align="center" rowspan="1" colspan="1">0</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">AA</td>
              <td align="left" rowspan="1" colspan="1">ASD Cases</td>
              <td align="center" rowspan="1" colspan="1">82</td>
              <td align="center" rowspan="1" colspan="1">2</td>
              <td align="center" rowspan="1" colspan="1">0.28</td>
              <td align="center" rowspan="1" colspan="1">2.00 CI<sub>95</sub>[0.2â8.1]</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td align="center" rowspan="1" colspan="1">EVS Controls</td>
              <td align="center" rowspan="1" colspan="1">2203</td>
              <td align="center" rowspan="1" colspan="1">27</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">CpG site disrupted or gained</td>
              <td align="left" rowspan="1" colspan="1">FC</td>
              <td align="left" rowspan="1" colspan="1">ASD Cases</td>
              <td align="center" rowspan="1" colspan="1">427</td>
              <td align="center" rowspan="1" colspan="1">5</td>
              <td align="center" rowspan="1" colspan="1">0.17</td>
              <td align="center" rowspan="1" colspan="1">2.37 CI<sub>95</sub>[0.6â9.4]</td>
              <td align="center" rowspan="1" colspan="1">6.8 Ã 10<sup>â3</sup></td>
              <td align="center" rowspan="1" colspan="1">2.5 CI<sub>95</sub>[1.3â4.7]</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Controls</td>
              <td align="center" rowspan="1" colspan="1">1214</td>
              <td align="center" rowspan="1" colspan="1">6</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">EA</td>
              <td align="left" rowspan="1" colspan="1">ASD Cases</td>
              <td align="center" rowspan="1" colspan="1">1892</td>
              <td align="center" rowspan="1" colspan="1">11</td>
              <td align="center" rowspan="1" colspan="1">0.02</td>
              <td align="center" rowspan="1" colspan="1">2.78 CI<sub>95</sub>[1.0â7.6]</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td align="center" rowspan="1" colspan="1">EVS Controls</td>
              <td align="center" rowspan="1" colspan="1">4300</td>
              <td align="center" rowspan="1" colspan="1">9</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">AA</td>
              <td align="left" rowspan="1" colspan="1">ASD Cases</td>
              <td align="center" rowspan="1" colspan="1">82</td>
              <td align="center" rowspan="1" colspan="1">2</td>
              <td align="center" rowspan="1" colspan="1">0.31</td>
              <td align="center" rowspan="1" colspan="1">1.85 CI<sub>95</sub>[0.2â7.5]</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td align="center" rowspan="1" colspan="1">EVS Controls</td>
              <td align="center" rowspan="1" colspan="1">2203</td>
              <td align="center" rowspan="1" colspan="1">29</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">CpG site not disrupted or gained</td>
              <td align="left" rowspan="1" colspan="1">FC</td>
              <td align="left" rowspan="1" colspan="1">ASD Cases</td>
              <td align="center" rowspan="1" colspan="1">427</td>
              <td align="center" rowspan="1" colspan="1">0</td>
              <td align="center" rowspan="1" colspan="1">1.00</td>
              <td align="center" rowspan="1" colspan="1">0.00 CI<sub>95</sub>[0.0-Inf]</td>
              <td align="center" rowspan="1" colspan="1">0.71</td>
              <td align="center" rowspan="1" colspan="1">0.42 CI<sub>95</sub>[0.0â3.6]</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Controls</td>
              <td align="center" rowspan="1" colspan="1">1214</td>
              <td align="center" rowspan="1" colspan="1">0</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">EA</td>
              <td align="left" rowspan="1" colspan="1">ASD Cases</td>
              <td align="center" rowspan="1" colspan="1">1892</td>
              <td align="center" rowspan="1" colspan="1">1</td>
              <td align="center" rowspan="1" colspan="1">0.67</td>
              <td align="center" rowspan="1" colspan="1">0.45 CI<sub>95</sub>[0.0â4.1]</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td align="center" rowspan="1" colspan="1">EVS Controls</td>
              <td align="center" rowspan="1" colspan="1">4300</td>
              <td align="center" rowspan="1" colspan="1">5</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">AA</td>
              <td align="left" rowspan="1" colspan="1">ASD Cases</td>
              <td align="center" rowspan="1" colspan="1">82</td>
              <td align="center" rowspan="1" colspan="1">0</td>
              <td align="center" rowspan="1" colspan="1">1.00</td>
              <td align="center" rowspan="1" colspan="1">0.00 CI<sub>95</sub>[0.0â65.6]</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td align="center" rowspan="1" colspan="1">EVS Controls</td>
              <td align="center" rowspan="1" colspan="1">2203</td>
              <td align="center" rowspan="1" colspan="1">3</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <table-wrap id="T5" position="float">
        <label>Table 5</label>
        <caption>
          <p><bold>Full gene rare variant (MAF &lt; 1%) analysis of <italic>SLC12A5</italic> using the SSC exome sequencing data</bold>.</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th rowspan="1" colspan="1"/>
              <th align="center" colspan="3" rowspan="1">Cohort</th>
              <th rowspan="1" colspan="1"/>
              <th rowspan="1" colspan="1"/>
              <th rowspan="1" colspan="1"/>
              <th align="center" colspan="2" rowspan="1">Combined</th>
            </tr>
            <tr>
              <th align="left" rowspan="1" colspan="1">Variant type</th>
              <th align="left" rowspan="1" colspan="1">Ethnicity</th>
              <th align="left" rowspan="1" colspan="1">Group</th>
              <th align="center" rowspan="1" colspan="1">Size</th>
              <th align="center" rowspan="1" colspan="1">Number of rare variants transported</th>
              <th align="center" rowspan="1" colspan="1"><italic>p</italic> value</th>
              <th align="center" rowspan="1" colspan="1">Odds ratio</th>
              <th align="center" rowspan="1" colspan="1"><italic>p</italic> value</th>
              <th align="center" rowspan="1" colspan="1">Odds ratio</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" rowspan="1" colspan="1">All</td>
              <td align="left" rowspan="1" colspan="1">EA</td>
              <td align="left" rowspan="1" colspan="1">ASD Cases</td>
              <td align="center" rowspan="1" colspan="1">1892</td>
              <td align="center" rowspan="1" colspan="1">50</td>
              <td align="center" rowspan="1" colspan="1">1.00</td>
              <td align="center" rowspan="1" colspan="1">1.00 CI<sub>95</sub>[0.7â1.4]</td>
              <td align="center" rowspan="1" colspan="1">0.76</td>
              <td align="center" rowspan="1" colspan="1">1.06 CI<sub>95</sub>[0.8â1.4]</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td align="center" rowspan="1" colspan="1">EVS Controls</td>
              <td align="center" rowspan="1" colspan="1">4300</td>
              <td align="center" rowspan="1" colspan="1">114</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">AA</td>
              <td align="left" rowspan="1" colspan="1">ASD Cases</td>
              <td align="center" rowspan="1" colspan="1">82</td>
              <td align="center" rowspan="1" colspan="1">9</td>
              <td align="center" rowspan="1" colspan="1">0.30</td>
              <td align="center" rowspan="1" colspan="1">1.44 CI<sub>95</sub>[0.6â2.9]</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td align="center" rowspan="1" colspan="1">EVS Controls</td>
              <td align="center" rowspan="1" colspan="1">2203</td>
              <td align="center" rowspan="1" colspan="1">168</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Non-synonymous</td>
              <td align="left" rowspan="1" colspan="1">EA</td>
              <td align="left" rowspan="1" colspan="1">ASD Cases</td>
              <td align="center" rowspan="1" colspan="1">1892</td>
              <td align="center" rowspan="1" colspan="1">21</td>
              <td align="center" rowspan="1" colspan="1">0.68</td>
              <td align="center" rowspan="1" colspan="1">1.11 CI<sub>95</sub>[0.6â1.9]</td>
              <td align="center" rowspan="1" colspan="1">0.98</td>
              <td align="center" rowspan="1" colspan="1">1.04 CI<sub>95</sub>[0.6â1.8]</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td align="center" rowspan="1" colspan="1">EVS Controls</td>
              <td align="center" rowspan="1" colspan="1">4300</td>
              <td align="center" rowspan="1" colspan="1">43</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">AA</td>
              <td align="left" rowspan="1" colspan="1">ASD Cases</td>
              <td align="center" rowspan="1" colspan="1">82</td>
              <td align="center" rowspan="1" colspan="1">0</td>
              <td align="center" rowspan="1" colspan="1">1.00</td>
              <td align="center" rowspan="1" colspan="1">0.00 CI<sub>95</sub>[0.0â4.8]</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td align="center" rowspan="1" colspan="1">EVS Controls</td>
              <td align="center" rowspan="1" colspan="1">2203</td>
              <td align="center" rowspan="1" colspan="1">23</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Synonymous</td>
              <td align="left" rowspan="1" colspan="1">EA</td>
              <td align="left" rowspan="1" colspan="1">ASD Cases</td>
              <td align="center" rowspan="1" colspan="1">1892</td>
              <td align="center" rowspan="1" colspan="1">29</td>
              <td align="center" rowspan="1" colspan="1">0.73</td>
              <td align="center" rowspan="1" colspan="1">1.08 CI<sub>95</sub>[0.7â1.7]</td>
              <td align="center" rowspan="1" colspan="1">0.38</td>
              <td align="center" rowspan="1" colspan="1">1.20 CI<sub>95</sub>[0.8â1.8]</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td align="center" rowspan="1" colspan="1">EVS Controls</td>
              <td align="center" rowspan="1" colspan="1">4300</td>
              <td align="center" rowspan="1" colspan="1">61</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">AA</td>
              <td align="left" rowspan="1" colspan="1">ASD Cases</td>
              <td align="center" rowspan="1" colspan="1">82</td>
              <td align="center" rowspan="1" colspan="1">9</td>
              <td align="center" rowspan="1" colspan="1">0.18</td>
              <td align="center" rowspan="1" colspan="1">1.67 CI<sub>95</sub>[0.7â3.4]</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td align="center" rowspan="1" colspan="1">EVS Controls</td>
              <td align="center" rowspan="1" colspan="1">2203</td>
              <td align="center" rowspan="1" colspan="1">145</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">CpG site disrupted or gained</td>
              <td align="left" rowspan="1" colspan="1">EA</td>
              <td align="left" rowspan="1" colspan="1">ASD Cases</td>
              <td align="center" rowspan="1" colspan="1">1892</td>
              <td align="center" rowspan="1" colspan="1">41</td>
              <td align="center" rowspan="1" colspan="1">0.22</td>
              <td align="center" rowspan="1" colspan="1">1.29 CI<sub>95</sub>[0.9â1.9]</td>
              <td align="center" rowspan="1" colspan="1">0.09</td>
              <td align="center" rowspan="1" colspan="1">1.37 CI<sub>95</sub>[1.0â1.9]</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td align="center" rowspan="1" colspan="1">EVS Controls</td>
              <td align="center" rowspan="1" colspan="1">4300</td>
              <td align="center" rowspan="1" colspan="1">72</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">AA</td>
              <td align="left" rowspan="1" colspan="1">ASD Cases</td>
              <td align="center" rowspan="1" colspan="1">82</td>
              <td align="center" rowspan="1" colspan="1">8</td>
              <td align="center" rowspan="1" colspan="1">0.15</td>
              <td align="center" rowspan="1" colspan="1">1.76 CI<sub>95</sub>[0.7â3.7]</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td align="center" rowspan="1" colspan="1">EVS Controls</td>
              <td align="center" rowspan="1" colspan="1">2203</td>
              <td align="center" rowspan="1" colspan="1">122</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">CpG site not disrupted or gained</td>
              <td align="left" rowspan="1" colspan="1">EA</td>
              <td align="left" rowspan="1" colspan="1">ASD Cases</td>
              <td align="center" rowspan="1" colspan="1">1892</td>
              <td align="center" rowspan="1" colspan="1">9</td>
              <td align="center" rowspan="1" colspan="1">0.05</td>
              <td align="center" rowspan="1" colspan="1">0.5 CI<sub>95</sub>[0.2â1.0]</td>
              <td align="center" rowspan="1" colspan="1">0.06</td>
              <td align="center" rowspan="1" colspan="1">0.50 CI<sub>95</sub>[0.3â1.0]</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td align="center" rowspan="1" colspan="1">EVS Controls</td>
              <td align="center" rowspan="1" colspan="1">4300</td>
              <td align="center" rowspan="1" colspan="1">42</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">AA</td>
              <td align="left" rowspan="1" colspan="1">ASD Cases</td>
              <td align="center" rowspan="1" colspan="1">82</td>
              <td align="center" rowspan="1" colspan="1">1</td>
              <td align="center" rowspan="1" colspan="1">1.00</td>
              <td align="center" rowspan="1" colspan="1">0.58 CI<sub>95</sub>[0.0â3.5]</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td align="center" rowspan="1" colspan="1">EVS Controls</td>
              <td align="center" rowspan="1" colspan="1">2203</td>
              <td align="center" rowspan="1" colspan="1">46</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <table-wrap id="T6" position="float">
        <label>Table 6</label>
        <caption>
          <p><bold>ASD case/control comparisons of the total number of variants that affect a CpG site vs. do not affect a CpG site from the full gene analysis</bold>.</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th align="left" colspan="2" rowspan="1">Cohort</th>
              <th align="center" rowspan="1" colspan="1">Total number of rare variants in <italic>SLC12A5</italic></th>
              <th align="center" colspan="2" rowspan="1">Variants that disrupt or gain a CpG site</th>
              <th align="center" colspan="2" rowspan="1">Variants that do not disrupt or gain a CpG site</th>
              <th rowspan="1" colspan="1"/>
              <th rowspan="1" colspan="1"/>
              <th align="center" colspan="2" rowspan="1">Combined</th>
            </tr>
            <tr>
              <th rowspan="1" colspan="1"/>
              <th rowspan="1" colspan="1"/>
              <th rowspan="1" colspan="1"/>
              <th align="center" rowspan="1" colspan="1">Number</th>
              <th align="center" rowspan="1" colspan="1">Percentage (%)</th>
              <th align="center" rowspan="1" colspan="1">Number</th>
              <th align="center" rowspan="1" colspan="1">Percentage (%)</th>
              <th align="center" rowspan="1" colspan="1"><italic>p</italic> value</th>
              <th align="center" rowspan="1" colspan="1">Odds ratio</th>
              <th align="center" rowspan="1" colspan="1"><italic>p</italic> value</th>
              <th align="center" rowspan="1" colspan="1">Odds ratio</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" rowspan="1" colspan="1">EA</td>
              <td align="center" rowspan="1" colspan="1">ASD Cases</td>
              <td align="center" rowspan="1" colspan="1">50</td>
              <td align="center" rowspan="1" colspan="1">41</td>
              <td align="center" rowspan="1" colspan="1">82</td>
              <td align="center" rowspan="1" colspan="1">9</td>
              <td align="center" rowspan="1" colspan="1">18</td>
              <td align="center" rowspan="1" colspan="1">0.02</td>
              <td align="center" rowspan="1" colspan="1">2.64 CI<sub>95</sub>[1.1â6.8]</td>
              <td align="center" rowspan="1" colspan="1">0.01</td>
              <td align="center" rowspan="1" colspan="1">2.71 CI<sub>95</sub>[1.3â5.8]</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="center" rowspan="1" colspan="1">EVS Controls</td>
              <td align="center" rowspan="1" colspan="1">114</td>
              <td align="center" rowspan="1" colspan="1">72</td>
              <td align="center" rowspan="1" colspan="1">63</td>
              <td align="center" rowspan="1" colspan="1">42</td>
              <td align="center" rowspan="1" colspan="1">37</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">AA</td>
              <td align="center" rowspan="1" colspan="1">ASD Cases</td>
              <td align="center" rowspan="1" colspan="1">9</td>
              <td align="center" rowspan="1" colspan="1">8</td>
              <td align="center" rowspan="1" colspan="1">89</td>
              <td align="center" rowspan="1" colspan="1">1</td>
              <td align="center" rowspan="1" colspan="1">11</td>
              <td align="center" rowspan="1" colspan="1">0.45</td>
              <td align="center" rowspan="1" colspan="1">3.00 CI<sub>95</sub>[0.4â136.6]</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="center" rowspan="1" colspan="1">EVS Controls</td>
              <td align="center" rowspan="1" colspan="1">168</td>
              <td align="center" rowspan="1" colspan="1">122</td>
              <td align="center" rowspan="1" colspan="1">73</td>
              <td align="center" rowspan="1" colspan="1">46</td>
              <td align="center" rowspan="1" colspan="1">38</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
    </sec>
    <sec sec-type="discussion" id="s4">
      <title>Discussion</title>
      <p>The identification of KCC2 NS genetic variants in ASD and SCZ cases that involve evolutionary conserved residues, are predicted to be pathogenic, and have either previously been shown [KCC2 R952H and R1049C (Kahle et al., <xref rid="B48" ref-type="bibr">2014</xref>; Puskarjov et al., <xref rid="B75" ref-type="bibr">2014</xref>)] or anticipated (KCC2 R1048W) to impact transporter function, trafficking, and/or regulatory phosphorylation, suggest that genetically-encoded impairment of KCC2 function may be risk factors for, or contribute to the pathogenesis of, human ASD and SCZ. Overall, these data are the first to describe functional KCC2 genetic variants in human psychiatric disease, and suggest a compelling genetic overlap among distinct NDs. Furthermore, we show that CpG sites in the targeted-screened 3â² end of <italic>SLC12A5</italic>, as well as in the entire gene, are more commonly affected (i.e., disrupted or gained) in ASD cases compared to controls.</p>
      <p>Genetic links among the different NDs have been previously shown. For example, chromosome 1q21.1 microdeletions exist in both ID and SCZ, and, interestingly, are often inherited from an unaffected or a mildly affected parent (Christiansen et al., <xref rid="B17" ref-type="bibr">2004</xref>; Brunetti-Pierri et al., <xref rid="B13" ref-type="bibr">2008</xref>; International-Schizophrenia-Consortium, <xref rid="B43" ref-type="bibr">2008</xref>; Mefford et al., <xref rid="B66" ref-type="bibr">2008</xref>; Stefansson et al., <xref rid="B82" ref-type="bibr">2008</xref>). Duplications of this region are also associated with mild to moderate ID and ASD (Brunetti-Pierri et al., <xref rid="B13" ref-type="bibr">2008</xref>; Mefford et al., <xref rid="B66" ref-type="bibr">2008</xref>). Deletions of chromosome 16p13.11 have been associated with ID and ASD (Ullmann et al., <xref rid="B88" ref-type="bibr">2007</xref>), and epilepsy (Heinzen et al., <xref rid="B39" ref-type="bibr">2010</xref>; de Kovel et al., <xref rid="B22" ref-type="bibr">2010</xref>), and duplications of this region have been documented in ID (Ullmann et al., <xref rid="B88" ref-type="bibr">2007</xref>; Mefford et al., <xref rid="B65" ref-type="bibr">2009</xref>), ASD (Ullmann et al., <xref rid="B88" ref-type="bibr">2007</xref>) and SCZ (Kirov et al., <xref rid="B53" ref-type="bibr">2009</xref>). In addition, mutations in <italic>MECP2</italic> [OMIM 300005] (Lam et al., <xref rid="B58" ref-type="bibr">2000</xref>) and <italic>SLC6A8</italic> [OMIM 300036] (Salomons et al., <xref rid="B78" ref-type="bibr">2001</xref>) have been found in both ID and ASD; and, mutations in <italic>SHANK3</italic> [OMIM 606230] have been identified in ASD (Durand et al., <xref rid="B26" ref-type="bibr">2007</xref>), SCZ (Gauthier et al., <xref rid="B31" ref-type="bibr">2010</xref>) and nonsyndromic ID cohorts (Hamdan et al., <xref rid="B35" ref-type="bibr">2011</xref>). The impact of <italic>de novo</italic> SNVs (single nucleotide variants) on sporadic forms of common NDs have also been increasingly appreciated (Vissers et al., <xref rid="B89" ref-type="bibr">2010</xref>; Girard et al., <xref rid="B33" ref-type="bibr">2011</xref>; OâRoak et al., <xref rid="B70" ref-type="bibr">2011</xref>, <xref rid="B71" ref-type="bibr">2012</xref>; Xu et al., <xref rid="B92" ref-type="bibr">2011</xref>; Iossifov et al., <xref rid="B45" ref-type="bibr">2012</xref>; Neale et al., <xref rid="B69" ref-type="bibr">2012</xref>; Sanders et al., <xref rid="B79" ref-type="bibr">2012</xref>), and <italic>de novo</italic> ASD mutations have been identified in genes previously associated with other NDs, such as <italic>FOXP1</italic> [OMIM 605515], <italic>GRIN2B</italic> [OMIM 138252], <italic>SCN1A</italic> [OMIM 182389], and <italic>LAMC3</italic> [OMIM 604349] (OâRoak et al., <xref rid="B70" ref-type="bibr">2011</xref>). No <italic>de novo</italic> variants were detected in this study.</p>
      <p>Identifying rare variants that are associated with a complex trait is most currently performed through whole-exome sequencing since there is a potential to identify many genes that underlie the trait at a substantially lower cost compared to whole-genome sequencing; plus, exome variants offer a clear-cut functional annotation that can be predicted through many <italic>in silico</italic> bioinformatics programs with an accuracy of ~80% (Kiezun et al., <xref rid="B52" ref-type="bibr">2012</xref>). However, with exome sequencing, a <italic>p</italic>-value of less than 2.5 Ã 10<sup>â6</sup> is required to reach genome-wide significance; this value accounts for multiple testing by making a Bonferroni correction for 20,000 independent tests (1 test for each gene in the genome). Such a threshold is very conservative and unless a study is extremely large, significant <italic>p</italic>-values will not be reached. In fact, current exome sequencing studies of complex traits are under-powered since, at minimum, 10,000 individuals with a distinct phenotype are needed in order to achieve the necessary power (Kryukov et al., <xref rid="B57" ref-type="bibr">2009</xref>; Kiezun et al., <xref rid="B52" ref-type="bibr">2012</xref>). Furthermore, rare variants should be combined in a gene (or pathway) during association tests in order to reach sufficient power (Purcell et al., <xref rid="B73" ref-type="bibr">2003</xref>; Kiezun et al., <xref rid="B52" ref-type="bibr">2012</xref>).</p>
      <p>A true understanding of how risk alleles interact and contribute to disease is yet to come. In a polygenic or oligogenic disease model, causality cannot be assigned to any one variant, but rather results from an individualâs variant pattern (Klassen et al., <xref rid="B54" ref-type="bibr">2011</xref>). A recent exome sequencing paper aimed to demonstrate the polygenic burden of rare disruptive mutations in SCZ by noting the disruptive mutations that were distributed across many genes as well as enriched gene sets (Purcell et al., <xref rid="B74" ref-type="bibr">2014</xref>). The ultimate goal is to identify all risk variants and to establish a computational modeling of biological networks in order to improve risk predictions based on a combination of alleles. Interestingly, Kiezun et al. (<xref rid="B52" ref-type="bibr">2012</xref>) noted that no individual gene-based test achieved significance after correction for multiple testing, again reiterating the need to increase sample size and/or take more targeted screening approaches to minimize multiple testing.</p>
      <p>Here, we utilized a hypothesis-driven, targeted sequencing approach to search for variation in the KCC2 CTRD in different NDs given the known neurophysiological importance of this gene (Gagnon and Delpire, <xref rid="B29" ref-type="bibr">2013</xref>), and the demonstrated critical role of our targeted region for the functional regulation of synapses (Chamma et al., <xref rid="B14" ref-type="bibr">2012</xref>; Kahle et al., <xref rid="B47" ref-type="bibr">2013</xref>). This approach previously enabled us to simplify the statistical analysis to identify the enrichment of NS alleles in the KCC2 CTRD in IGE cases vs. controls (<italic>p-value</italic> = 7.50 Ã 10<sup>â3</sup>; Kahle et al., <xref rid="B48" ref-type="bibr">2014</xref>). Rare variation is enriched for evolutionarily deleterious variants, and we demonstrated that the KCC2 IGE variants (R952H and R1049C) impaired KCC2 function (Kahle et al., <xref rid="B48" ref-type="bibr">2014</xref>). The initial targeted screening of the KCC2 CTRD in the FC cohort of ASD, SCZ, and ID did not generate any significant associations; however, it revealed that the functional variants overlap across different NDs, suggesting a role in disease pathogenesis, and the effects of these variants are likely dependent on the combination of other alleles within each individual. After combining our initial findings with the results of other exome sequencing projects (Iossifov et al., <xref rid="B44" ref-type="bibr">2014</xref>), we were able to generate improved <italic>p</italic>-values due to the larger sample sets. It was after this analysis that a statistically significant excess of KCC2 CTRD variants in the targeted region was identified in ASD cases compared to controls, as well as an increase of variants that affected CpG sites. It should be noted that the authors recognize the disadvantages of comparing different exome sequencing data sets (SSC and EVS) that were analyzed using different pipelines; replication studies are warranted.</p>
      <p>What is the functional impact of the discovered KCC2 variants? The KCC2 R952H and R1049C variants significantly decrease KCC2-mediated Cl<sup>â</sup> extrusion capacity in neurons, render E<sub>Gly</sub> less hyperpolarized compared to WT KCC2, decrease the level of KCC2 Ser940 phosphorylation, act in a dominant-negative manner, and decrease transporter plasmalemmal expression (R952H) or lower the intrinsic activity of transporters at the cell surface (R1049C). KCC2 R952H was also shown to substantially decrease dendritic spine density and alter spine morphology (Puskarjov et al., <xref rid="B75" ref-type="bibr">2014</xref>). Given the evolutionary conservation of KCC2 R1048, the predicted pathogenicity of the R1048W substitution by multiple <italic>in silico</italic> algorithms, and the proximity of this variation to R1049, we anticipate the R1048W KCC2 variant detected in ASD, like R1049C, alters the intrinsic activity of KCC2 transporters at the cell surface. The clustering of the R1048 and R1049 variants suggests this region of KCC2 is particularly important for transporter regulation. Consistent with this is the proximity of the KCC2 âISOâ domain, encoded in amino acids 1022â1037, which is required for isotonic KCC2-mediated hyperpolarizing GABAergic transmission (Acton et al., <xref rid="B3" ref-type="bibr">2012</xref>). These variants might change C-terminal protein structure and alter the function of the âISOâ domain, perhaps by disrupting the binding of key associated regulatory molecules.</p>
      <p>From a pathophysiological standpoint, decreased KCC2-mediated Cl<sup>â</sup> efflux in individuals carrying the KCC2 R952H, R1048W, and R1049C variants would be anticipated to increase intracellular [Cl<sup>â</sup>], raising the Cl<sup>â</sup> reversal potential (E<sub>Cl</sub>) to less hyperpolarized potentials, and compromising GABA<sub>A</sub>R-mediated hyperpolarizing inhibition. In humans, KCC2 is developmentally upregulated, with low expression <italic>in utero</italic>, a rapid increase in expression around 40 postconceptional weeks, and progressively increasing levels of expression into adulthood (Dzhala et al., <xref rid="B27" ref-type="bibr">2005</xref>). This pattern of expression drives the developmental switch of GABAergic signaling from depolarizing in early development to hyperpolarizing in adulthood, but the precise role of KCC2 or its disruption in neurodevelopment is unclear. The progressive developmental increase in KCC2 expression into adulthood might be expected to amplify the functional effects of KCC2 variants on CNS function over time. This may correlate with the age of onset of these neuropsychiatric disorders, as clinical symptomatology might manifest only after years of neurodevelopment over which deficits in KCC2 activity relative to normal become more pronounced. Further studies are indicated to explore this hypothesis.</p>
      <p>The effects of KCC2 variants identified in this study might be similar, though less potent in magnitude given their heterozygousity, to phenotypes observed in mice with complete knockout or mild dysfunction of KCC2. Mice with complete KCC2 knockout die at birth from profound motor deficits that abolish respiratory function (Hekmat-Scafe et al., <xref rid="B40" ref-type="bibr">2006</xref>, <xref rid="B41" ref-type="bibr">2010</xref>; Tanis et al., <xref rid="B84" ref-type="bibr">2009</xref>; Bellemer et al., <xref rid="B7" ref-type="bibr">2011</xref>), but, interestingly, mice expressing hypomorphic alleles that reduce but do not abolish KCC2 activity demonstrate anxiety-like behavior, impaired spatial learning, and decreased seizure threshold (Woo et al., <xref rid="B91" ref-type="bibr">2002</xref>; Tornberg et al., <xref rid="B85" ref-type="bibr">2005</xref>; Zhu et al., <xref rid="B93" ref-type="bibr">2008</xref>). Together, these data indicate that regulation of Cl<sup>â</sup> homeostasis and GABAergic signaling by KCC2 plays a role in multiple functional systems of the CNS. These studies have also demonstrated that genetic KCC2 knockdown is not accompanied by compensatory changes in the expression of NKCC1 or other KCC isoforms, although post-translational compensatory regulation (e.g., phosphorylation) cannot be ruled out (Hubner et al., <xref rid="B42" ref-type="bibr">2001</xref>; Woo et al., <xref rid="B91" ref-type="bibr">2002</xref>; Tornberg et al., <xref rid="B85" ref-type="bibr">2005</xref>).</p>
      <p>Compellingly, CpG sites in the screened 3â² end of <italic>SLC12A5</italic>, as well as in the entire gene, are more commonly affected (i.e., disrupted or gained) in ASD cases compared to controls. Generally, DNA methylation occurs at CpG sites and plays a role in gene expression by suppressing gene transcription. Therefore, differences in methylation patterns between cases and controls could result in different gene expression patterns that increase risk to ASD. CpG islands, regions of CpG clusters that are associated with genes, are generally involved in transcription activation. Interestingly, there is a CpG island of ~2000bp at the 3â² end of <italic>SLC12A5</italic> that partially overlaps with our targeted-screened region. Furthermore, despite the fact that the variants detected in our targeted-screened region are outside that specific CpG island, most methylation differences between tissues and, perhaps even between patients and controls, actually occur at CpG sites at a short distance from the actual CpG island (Irizarry et al., <xref rid="B46" ref-type="bibr">2009</xref>). It would be interesting to screen the entire <italic>SLC12A5</italic> locus (coding and non-coding regions) to determine if non-coding variants contribute towards a stronger association in ASD cases and controls. Additionally, carrying out the same analysis in an SCZ case/control cohort would be valuable.</p>
      <p>Lastly, our results are interesting given the recent data from the Fragile X and valproate mouse models of autism, which demonstrate an abnormally prolonged elevation of [Cl<sup>â</sup>]<sub>i</sub> in developing CNS neurons that delays the normal ontogenic switch to GABA inhibition (He et al., <xref rid="B38" ref-type="bibr">2014</xref>). Maternal oxytocin during delivery normally mediates the hyperpolarization of E<sub>GABA</sub>, but this effect is abolished in the these models (Tyzio et al., <xref rid="B87" ref-type="bibr">2014</xref>). Our data here suggest a compelling hypothesis that abnormally delayed KCC2-mediated Cl<sup>â</sup> extrusion during the developmental GABA excitatory-inhibitory sequence might be a genetically programmed factor contributing to ASD. Further investigation into the roles of KCC2 in ASD and SCZ, and potentially other NDs, may offer new therapeutic strategies.</p>
    </sec>
    <sec id="s5">
      <title>Conflict of Interest Statement</title>
      <p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
    </sec>
  </body>
  <back>
    <ack>
      <p>The authors thank JingJing Duan (Harvard Medical School, Boston, MA), Jin Zhang (Harvard Medical School, Boston, MA), and Jinwei Zhang (University of Dundee, Dundee, Scotland) for their technical support and assistance in conducting the experiments described in this study.</p>
    </ack>
    <fn-group>
      <fn id="fn0001">
        <p>
          <sup>1</sup>
          <ext-link ext-link-type="uri" xlink:href="http://evs.gs.washington.edu/EVS/">http://evs.gs.washington.edu/EVS/</ext-link>
        </p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="B3">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Acton</surname><given-names>B. A.</given-names></name><name><surname>Mahadevan</surname><given-names>V.</given-names></name><name><surname>Mercado</surname><given-names>A.</given-names></name><name><surname>Uvarov</surname><given-names>P.</given-names></name><name><surname>Ding</surname><given-names>Y.</given-names></name><name><surname>Pressey</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>2012</year>). <article-title>Hyperpolarizing GABAergic transmission requires the KCC2 C-terminal ISO domain</article-title>. <source>J. Neurosci.</source>
<volume>32</volume>, <fpage>8746</fpage>â<lpage>8751</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.6089-11.2012</pub-id><?supplied-pmid 22723714?><pub-id pub-id-type="pmid">22723714</pub-id></mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adzhubei</surname><given-names>I. A.</given-names></name><name><surname>Schmidt</surname><given-names>S.</given-names></name><name><surname>Peshkin</surname><given-names>L.</given-names></name><name><surname>Ramensky</surname><given-names>V. E.</given-names></name><name><surname>Gerasimova</surname><given-names>A.</given-names></name><name><surname>Bork</surname><given-names>P.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title>A method and server for predicting damaging missense mutations</article-title>. <source>Nat. Methods.</source>
<volume>7</volume>, <fpage>248</fpage>â<lpage>249</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth0410-248</pub-id><?supplied-pmid 20354512?><pub-id pub-id-type="pmid">20354512</pub-id></mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Awadalla</surname><given-names>P.</given-names></name><name><surname>Gauthier</surname><given-names>J.</given-names></name><name><surname>Myers</surname><given-names>R. A.</given-names></name><name><surname>Casals</surname><given-names>F.</given-names></name><name><surname>Hamdan</surname><given-names>F. F.</given-names></name><name><surname>Griffing</surname><given-names>A. R.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title>Direct measure of the de novo mutation rate in autism and schizophrenia cohorts</article-title>. <source>Am. J. Hum. Genet.</source>
<volume>87</volume>, <fpage>316</fpage>â<lpage>324</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2010.07.019</pub-id><?supplied-pmid 20797689?><pub-id pub-id-type="pmid">20797689</pub-id></mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belhage</surname><given-names>B.</given-names></name><name><surname>Hansen</surname><given-names>G. H.</given-names></name><name><surname>Elster</surname><given-names>L.</given-names></name><name><surname>Schousboe</surname><given-names>A.</given-names></name></person-group> (<year>1998</year>). <article-title>Effects of gamma-aminobutyric acid (GABA) on synaptogenesis and synaptic function</article-title>. <source>Perspect Dev. Neurobiol.</source>
<volume>5</volume>, <fpage>235</fpage>â<lpage>246</lpage>. <?supplied-pmid 9777639?><pub-id pub-id-type="pmid">9777639</pub-id></mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bellemer</surname><given-names>A.</given-names></name><name><surname>Hirata</surname><given-names>T.</given-names></name><name><surname>Romero</surname><given-names>M. F.</given-names></name><name><surname>Koelle</surname><given-names>M. R.</given-names></name></person-group> (<year>2011</year>). <article-title>Two types of chloride transporters are required for GABA(A) receptor-mediated inhibition in C. elegans</article-title>. <source>EMBO. J.</source>
<volume>30</volume>, <fpage>1852</fpage>â<lpage>1863</lpage>. <pub-id pub-id-type="doi">10.1038/emboj.2011.83</pub-id><?supplied-pmid 21427702?><pub-id pub-id-type="pmid">21427702</pub-id></mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ben-Ari</surname><given-names>Y.</given-names></name><name><surname>Cherubini</surname><given-names>E.</given-names></name><name><surname>Corradetti</surname><given-names>R.</given-names></name><name><surname>Gaiarsa</surname><given-names>J. L.</given-names></name></person-group> (<year>1989</year>). <article-title>Giant synaptic potentials in immature rat CA3 hippocampal neurones</article-title>. <source>J. Physiol.</source>
<volume>416</volume>, <fpage>303</fpage>â<lpage>325</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.1989.sp017762</pub-id><pub-id pub-id-type="pmid">2575165</pub-id></mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blaesse</surname><given-names>P.</given-names></name><name><surname>Airaksinen</surname><given-names>M. S.</given-names></name><name><surname>Rivera</surname><given-names>C.</given-names></name><name><surname>Kaila</surname><given-names>K.</given-names></name></person-group> (<year>2009</year>). <article-title>Cation-chloride cotransporters and neuronal function</article-title>. <source>Neuron.</source>
<volume>61</volume>, <fpage>820</fpage>â<lpage>838</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2009.03.003</pub-id><?supplied-pmid 19323993?><pub-id pub-id-type="pmid">19323993</pub-id></mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bozzi</surname><given-names>Y.</given-names></name><name><surname>Casarosa</surname><given-names>S.</given-names></name><name><surname>Caleo</surname><given-names>M.</given-names></name></person-group> (<year>2012</year>). <article-title>Epilepsy as a neurodevelopmental disorder</article-title>. <source>Frontiers in Psychiatry.</source>
<volume>3</volume>:<fpage>19</fpage>. <pub-id pub-id-type="doi">10.3389/fpsyt.2012.00019</pub-id><?supplied-pmid 22457654?><pub-id pub-id-type="pmid">22457654</pub-id></mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braat</surname><given-names>S.</given-names></name><name><surname>Kooy</surname><given-names>R. F.</given-names></name></person-group> (<year>2015</year>). <article-title>The GABA Receptor as a Therapeutic Target for Neurodevelopmental Disorders</article-title>. <source>Neuron.</source>
<volume>86</volume>, <fpage>1119</fpage>â<lpage>1130</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2015.03.042</pub-id><?supplied-pmid 26050032?><pub-id pub-id-type="pmid">26050032</pub-id></mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brooks-Kayal</surname><given-names>A.</given-names></name></person-group> (<year>2010</year>). <article-title>Epilepsy and autism spectrum disorders: Are there common developmental mechanisms?</article-title>
<source>Brain and Development.</source>
<volume>32</volume>, <fpage>731</fpage>â<lpage>738</lpage>. <pub-id pub-id-type="doi">10.1016/j.braindev.2010.04.010</pub-id><?supplied-pmid 20570072?><pub-id pub-id-type="pmid">20570072</pub-id></mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brunetti-Pierri</surname><given-names>N.</given-names></name><name><surname>Berg</surname><given-names>J. S.</given-names></name><name><surname>Scaglia</surname><given-names>F.</given-names></name><name><surname>Belmont</surname><given-names>J.</given-names></name><name><surname>Bacino</surname><given-names>C. A.</given-names></name><name><surname>Sahoo</surname><given-names>T.</given-names></name><etal/></person-group>. (<year>2008</year>). <article-title>Recurrent reciprocal 1q21.1 deletions and duplications associated with microcephaly or macrocephaly and developmental and behavioral abnormalities</article-title>. <source>Nat. Genet.</source>
<volume>40</volume>, <fpage>1466</fpage>â<lpage>1471</lpage>. <pub-id pub-id-type="doi">10.1038/ng.279</pub-id><?supplied-pmid 26333794?><pub-id pub-id-type="pmid">19029900</pub-id></mixed-citation>
      </ref>
      <ref id="B14">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chamma</surname><given-names>I.</given-names></name><name><surname>Chevy</surname><given-names>Q.</given-names></name><name><surname>Poncer</surname><given-names>J. C.</given-names></name><name><surname>LÃ©vi</surname><given-names>S.</given-names></name></person-group> (<year>2012</year>). <article-title>Role of the neuronal K-Cl co-transporter KCC2 in inhibitory and excitatory neurotransmission</article-title>. <source>Front. Cell. Neurosci.</source>
<volume>6</volume>:<fpage>5</fpage>. <pub-id pub-id-type="doi">10.3389/fncel.2012.00005</pub-id><?supplied-pmid 22363264?><pub-id pub-id-type="pmid">22363264</pub-id></mixed-citation>
      </ref>
      <ref id="B15">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>Y. T.</given-names></name><name><surname>Chen</surname><given-names>P. C.</given-names></name><name><surname>Tsai</surname><given-names>I. J.</given-names></name><name><surname>Sung</surname><given-names>F. C.</given-names></name><name><surname>Chin</surname><given-names>Z. N.</given-names></name><name><surname>Kuo</surname><given-names>H. T.</given-names></name><etal/></person-group>. (<year>2011</year>). <article-title>Bidirectional relation between schizophrenia and epilepsy: a population-based retrospective cohort study</article-title>. <source>Epilepsia.</source>
<volume>52</volume>, <fpage>2036</fpage>â<lpage>2042</lpage>. <pub-id pub-id-type="doi">10.1111/j.1528-1167.2011.03268.x</pub-id><?supplied-pmid 21929680?><pub-id pub-id-type="pmid">21929680</pub-id></mixed-citation>
      </ref>
      <ref id="B16">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chao</surname><given-names>H. T.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Samaco</surname><given-names>R. C.</given-names></name><name><surname>Xue</surname><given-names>M.</given-names></name><name><surname>Chahrour</surname><given-names>M.</given-names></name><name><surname>Yoo</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title>Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes</article-title>. <source>Nature.</source>
<volume>468</volume>, <fpage>263</fpage>â<lpage>269</lpage>. <pub-id pub-id-type="doi">10.1038/nature09582</pub-id><?supplied-pmid 21068835?><pub-id pub-id-type="pmid">21068835</pub-id></mixed-citation>
      </ref>
      <ref id="B17">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christiansen</surname><given-names>J.</given-names></name><name><surname>Dyck</surname><given-names>J. D.</given-names></name><name><surname>Elyas</surname><given-names>B. G.</given-names></name><name><surname>Lilley</surname><given-names>M.</given-names></name><name><surname>Bamforth</surname><given-names>J. S.</given-names></name><name><surname>Hicks</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2004</year>). <article-title>Chromosome 1q21.1 contiguous gene deletion is associated with congenital heart disease</article-title>. <source>Circ. Res.</source>
<volume>94</volume>, <fpage>1429</fpage>â<lpage>1435</lpage>. <pub-id pub-id-type="doi">10.1161/01.res.0000130528.72330.5c</pub-id><?supplied-pmid 15117819?><pub-id pub-id-type="pmid">15117819</pub-id></mixed-citation>
      </ref>
      <ref id="B18">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coe</surname><given-names>B. P.</given-names></name><name><surname>Girirajan</surname><given-names>S.</given-names></name><name><surname>Eichler</surname><given-names>E. E.</given-names></name></person-group> (<year>2012</year>). <article-title>The genetic variability and commonality of neurodevelopmental disease</article-title>. <source>Am. J. Med. Genet. C. Semin. Med. Genet.</source>
<volume>160C</volume>, <fpage>118</fpage>â<lpage>129</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.c.31327</pub-id><?supplied-pmid 22499536?><pub-id pub-id-type="pmid">22499536</pub-id></mixed-citation>
      </ref>
      <ref id="B19">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coghlan</surname><given-names>S.</given-names></name><name><surname>Horder</surname><given-names>J.</given-names></name><name><surname>Inkster</surname><given-names>B.</given-names></name><name><surname>Mendez</surname><given-names>M. A.</given-names></name><name><surname>Murphy</surname><given-names>D. G.</given-names></name><name><surname>Nutt</surname><given-names>D. J.</given-names></name></person-group> (<year>2012</year>). <article-title>GABA system dysfunction in autism and related disorders: From synapse to symptoms</article-title>. <source>Neurosci. Biobehav. Rev.</source>
<volume>36</volume>, <fpage>2044</fpage>â<lpage>2055</lpage>. <pub-id pub-id-type="doi">10.1016/j.neubiorev.2012.07.005</pub-id><?supplied-pmid 22841562?><pub-id pub-id-type="pmid">22841562</pub-id></mixed-citation>
      </ref>
      <ref id="B20">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crooks</surname><given-names>G. E.</given-names></name><name><surname>Hon</surname><given-names>G.</given-names></name><name><surname>Chandonia</surname><given-names>J. M.</given-names></name><name><surname>Brenner</surname><given-names>S. E.</given-names></name></person-group> (<year>2004</year>). <article-title>WebLogo: a sequence logo generator</article-title>. <source>Genome Res.</source>
<volume>14</volume>, <fpage>1188</fpage>â<lpage>1190</lpage>. <pub-id pub-id-type="doi">10.1101/gr.849004</pub-id><?supplied-pmid 15173120?><pub-id pub-id-type="pmid">15173120</pub-id></mixed-citation>
      </ref>
      <ref id="B21">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname><given-names>Y.</given-names></name><name><surname>Costa</surname><given-names>R. M.</given-names></name><name><surname>Murphy</surname><given-names>G. G.</given-names></name><name><surname>Elgersma</surname><given-names>Y.</given-names></name><name><surname>Zhu</surname><given-names>Y.</given-names></name><name><surname>Gutmann</surname><given-names>D. H.</given-names></name><etal/></person-group>. (<year>2008</year>). <article-title>Neurofibromin regulation of ERK signaling modulates GABA release and learning</article-title>. <source>Cell.</source>
<volume>135</volume>, <fpage>549</fpage>â<lpage>560</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2008.09.060</pub-id><?supplied-pmid 18984165?><pub-id pub-id-type="pmid">18984165</pub-id></mixed-citation>
      </ref>
      <ref id="B22">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Kovel</surname><given-names>C. G.</given-names></name><name><surname>Trucks</surname><given-names>H.</given-names></name><name><surname>Helbig</surname><given-names>I.</given-names></name><name><surname>Mefford</surname><given-names>H. C.</given-names></name><name><surname>Baker</surname><given-names>C.</given-names></name><name><surname>Leu</surname><given-names>C.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title>Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies</article-title>. <source>Brain.</source>
<volume>133</volume>, <fpage>23</fpage>â<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awp262</pub-id><?supplied-pmid 19843651?><pub-id pub-id-type="pmid">19843651</pub-id></mixed-citation>
      </ref>
      <ref id="B23">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Los Heros</surname><given-names>P.</given-names></name><name><surname>Alessi</surname><given-names>D. R.</given-names></name><name><surname>Gourlay</surname><given-names>R.</given-names></name><name><surname>Campbell</surname><given-names>D. G.</given-names></name><name><surname>Deak</surname><given-names>M.</given-names></name><name><surname>Macartney</surname><given-names>T. J.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>The WNK-regulated SPAK/OSR1 kinases directly phosphorylate and inhibit the K+-Clâ co-transporters</article-title>. <source>Biochem. J.</source>
<volume>458</volume>, <fpage>559</fpage>â<lpage>573</lpage>. <pub-id pub-id-type="doi">10.1042/bj20131478</pub-id><?supplied-pmid 24393035?><pub-id pub-id-type="pmid">24393035</pub-id></mixed-citation>
      </ref>
      <ref id="B24">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Rubeis</surname><given-names>S.</given-names></name><name><surname>He</surname><given-names>X.</given-names></name><name><surname>Goldberg</surname><given-names>A. P.</given-names></name><name><surname>Poultney</surname><given-names>C. S.</given-names></name><name><surname>Samocha</surname><given-names>K.</given-names></name><name><surname>Cicek</surname><given-names>A. E.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Synaptic, transcriptional and chromatin genes disrupted in autism</article-title>. <source>Nature.</source>
<volume>515</volume>, <fpage>209</fpage>â<lpage>215</lpage>. <pub-id pub-id-type="doi">10.1038/nature13772</pub-id><?supplied-pmid 25363760?><pub-id pub-id-type="pmid">25363760</pub-id></mixed-citation>
      </ref>
      <ref id="B25">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deidda</surname><given-names>G.</given-names></name><name><surname>Bozarth</surname><given-names>I. F.</given-names></name><name><surname>Cancedda</surname><given-names>L.</given-names></name></person-group> (<year>2014</year>). <article-title>Modulation of GABAergic transmission in development and neurodevelopmental disorders: investigating physiology and pathology to gain therapeutic perspectives</article-title>. <source>Front. Cell. Neurosci.</source>
<volume>8</volume>:<fpage>119</fpage>. <pub-id pub-id-type="doi">10.3389/fncel.2014.00119</pub-id><?supplied-pmid 24904277?><pub-id pub-id-type="pmid">24904277</pub-id></mixed-citation>
      </ref>
      <ref id="B26">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durand</surname><given-names>C. M.</given-names></name><name><surname>Betancur</surname><given-names>C.</given-names></name><name><surname>Boeckers</surname><given-names>T. M.</given-names></name><name><surname>Bockmann</surname><given-names>J.</given-names></name><name><surname>Chaste</surname><given-names>P.</given-names></name><name><surname>Fauchereau</surname><given-names>F.</given-names></name><etal/></person-group>. (<year>2007</year>). <article-title>Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders</article-title>. <source>Nat. Genet.</source>
<volume>39</volume>, <fpage>25</fpage>â<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1038/ng1933</pub-id><?supplied-pmid 17173049?><pub-id pub-id-type="pmid">17173049</pub-id></mixed-citation>
      </ref>
      <ref id="B27">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dzhala</surname><given-names>V. I.</given-names></name><name><surname>Talos</surname><given-names>D. M.</given-names></name><name><surname>Sdrulla</surname><given-names>D. A.</given-names></name><name><surname>Brumback</surname><given-names>A. C.</given-names></name><name><surname>Mathews</surname><given-names>G. C.</given-names></name><name><surname>Benke</surname><given-names>T. A.</given-names></name><etal/></person-group>. (<year>2005</year>). <article-title>NKCC1 transporter facilitates seizures in the developing brain</article-title>. <source>Nat. Med.</source>
<volume>11</volume>, <fpage>1205</fpage>â<lpage>1213</lpage>. <pub-id pub-id-type="doi">10.1038/nm1301</pub-id><?supplied-pmid 16227993?><pub-id pub-id-type="pmid">16227993</pub-id></mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>EPGP Collaborative</collab><name><surname>Abou-Khalil</surname><given-names>B.</given-names></name><name><surname>Alldredge</surname><given-names>B.</given-names></name><name><surname>Bautista</surname><given-names>J.</given-names></name><name><surname>Berkovic</surname><given-names>S.</given-names></name><name><surname>Bluvstein</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>The epilepsy phenome/genome project</article-title>. <source>Clin. Trials.</source>
<volume>10</volume>, <fpage>568</fpage>â<lpage>586</lpage>. <pub-id pub-id-type="doi">10.1177/1740774513484392</pub-id><?supplied-pmid 23818435?><pub-id pub-id-type="pmid">23818435</pub-id></mixed-citation>
      </ref>
      <ref id="B28">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischbach</surname><given-names>G. D.</given-names></name><name><surname>Lord</surname><given-names>C.</given-names></name></person-group> (<year>2010</year>). <article-title>The Simons Simplex Collection: a resource for identification of autism genetic risk factors</article-title>. <source>Neuron.</source>
<volume>68</volume>, <fpage>192</fpage>â<lpage>195</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2010.10.006</pub-id><?supplied-pmid 20955926?><pub-id pub-id-type="pmid">20955926</pub-id></mixed-citation>
      </ref>
      <ref id="B29">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gagnon</surname><given-names>K. B.</given-names></name><name><surname>Delpire</surname><given-names>E.</given-names></name></person-group> (<year>2013</year>). <article-title>Physiology of SLC12 transporters: lessons from inherited human genetic mutations and genetically engineered mouse knockouts</article-title>. <source>Am. J. Physiol. Cell. Physiol.</source>
<volume>304</volume>, <fpage>C693</fpage>â<lpage>C714</lpage>. <pub-id pub-id-type="doi">10.1152/ajpcell.00350.2012</pub-id><?supplied-pmid 23325410?><pub-id pub-id-type="pmid">23325410</pub-id></mixed-citation>
      </ref>
      <ref id="B30">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gauthier</surname><given-names>J.</given-names></name><name><surname>Bonnel</surname><given-names>A.</given-names></name><name><surname>St-Onge</surname><given-names>J.</given-names></name><name><surname>Karemera</surname><given-names>L.</given-names></name><name><surname>Laurent</surname><given-names>S.</given-names></name><name><surname>Mottron</surname><given-names>L.</given-names></name><etal/></person-group>. (<year>2005</year>). <article-title>NLGN3/NLGN4 gene mutations are not responsible for autism in the Quebec population</article-title>. <source>Am. J. Med. Genet. B. Neuropsychiatr. Genet.</source>
<volume>132B</volume>, <fpage>74</fpage>â<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.b.30066</pub-id><?supplied-pmid 15389766?><pub-id pub-id-type="pmid">15389766</pub-id></mixed-citation>
      </ref>
      <ref id="B31">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gauthier</surname><given-names>J.</given-names></name><name><surname>Champagne</surname><given-names>N.</given-names></name><name><surname>LafreniÃ©re</surname><given-names>R. G.</given-names></name><name><surname>Xiong</surname><given-names>L.</given-names></name><name><surname>Spiegelman</surname><given-names>D.</given-names></name><name><surname>Brustein</surname><given-names>E.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title>De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source>
<volume>107</volume>, <fpage>7863</fpage>â<lpage>7868</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0906232107</pub-id><?supplied-pmid 20385823?><pub-id pub-id-type="pmid">20385823</pub-id></mixed-citation>
      </ref>
      <ref id="B32">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilman</surname><given-names>S. R.</given-names></name><name><surname>Iossifov</surname><given-names>I.</given-names></name><name><surname>Levy</surname><given-names>D.</given-names></name><name><surname>Ronemus</surname><given-names>M.</given-names></name><name><surname>Wigler</surname><given-names>M.</given-names></name><name><surname>Vitkup</surname><given-names>D.</given-names></name></person-group> (<year>2011</year>). <article-title>Rare de novo variants associated with autism implicate a large functional network of genes involved in formation and function of synapses</article-title>. <source>Neuron.</source>
<volume>70</volume>, <fpage>898</fpage>â<lpage>907</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2011.05.021</pub-id><?supplied-pmid 21658583?><pub-id pub-id-type="pmid">21658583</pub-id></mixed-citation>
      </ref>
      <ref id="B33">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Girard</surname><given-names>S. L.</given-names></name><name><surname>Gauthier</surname><given-names>J.</given-names></name><name><surname>Noreau</surname><given-names>A.</given-names></name><name><surname>Xiong</surname><given-names>L.</given-names></name><name><surname>Zhou</surname><given-names>S.</given-names></name><name><surname>Jouan</surname><given-names>L.</given-names></name><etal/></person-group>. (<year>2011</year>). <article-title>Increased exonic de novo mutation rate in individuals with schizophrenia</article-title>. <source>Nat. Genet.</source>
<volume>43</volume>, <fpage>860</fpage>â<lpage>863</lpage>. <pub-id pub-id-type="doi">10.1038/ng.886</pub-id><?supplied-pmid 21743468?><pub-id pub-id-type="pmid">21743468</pub-id></mixed-citation>
      </ref>
      <ref id="B34">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guilmatre</surname><given-names>A.</given-names></name><name><surname>Dubourg</surname><given-names>C.</given-names></name><name><surname>Mosca</surname><given-names>A. L.</given-names></name><name><surname>Legallic</surname><given-names>S.</given-names></name><name><surname>Goldenberg</surname><given-names>A.</given-names></name><name><surname>Drouin-Garraud</surname><given-names>V.</given-names></name><etal/></person-group>. (<year>2009</year>). <article-title>Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism and mental retardation</article-title>. <source>Arch. Gen. Psychiatry.</source>
<volume>66</volume>, <fpage>947</fpage>â<lpage>956</lpage>. <pub-id pub-id-type="doi">10.1001/archgenpsychiatry.2009.80</pub-id><?supplied-pmid 19736351?><pub-id pub-id-type="pmid">19736351</pub-id></mixed-citation>
      </ref>
      <ref id="B35">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamdan</surname><given-names>F. F.</given-names></name><name><surname>Gauthier</surname><given-names>J.</given-names></name><name><surname>Araki</surname><given-names>Y.</given-names></name><name><surname>Lin</surname><given-names>D. T.</given-names></name><name><surname>Yoshizawa</surname><given-names>Y.</given-names></name><name><surname>Higashi</surname><given-names>K.</given-names></name><etal/></person-group>. (<year>2011</year>). <article-title>Excess of de novo deleterious mutations in genes associated with glutamatergic systems in nonsyndromic intellectual disability</article-title>. <source>Am. J. Hum. Genet.</source>
<volume>88</volume>, <fpage>306</fpage>â<lpage>316</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2011.02.001</pub-id><?supplied-pmid 21376300?><pub-id pub-id-type="pmid">21376300</pub-id></mixed-citation>
      </ref>
      <ref id="B36">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamdan</surname><given-names>F. F.</given-names></name><name><surname>Gauthier</surname><given-names>J.</given-names></name><name><surname>Spiegelman</surname><given-names>D.</given-names></name><name><surname>Noreau</surname><given-names>A.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Pellerin</surname><given-names>S.</given-names></name><etal/></person-group>. (<year>2009</year>). <article-title>Mutations in SYNGAP1 in autosomal nonsyndromic mental retardation</article-title>. <source>N. Engl. J. Med.</source>
<volume>360</volume>, <fpage>599</fpage>â<lpage>605</lpage>. <pub-id pub-id-type="doi">10.1056/nejmoa0805392</pub-id><?supplied-pmid 19196676?><pub-id pub-id-type="pmid">19196676</pub-id></mixed-citation>
      </ref>
      <ref id="B37">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hashimoto</surname><given-names>T.</given-names></name><name><surname>Arion</surname><given-names>D.</given-names></name><name><surname>Unger</surname><given-names>T.</given-names></name><name><surname>Maldonado-Aviles</surname><given-names>J. G.</given-names></name><name><surname>Morris</surname><given-names>H. M.</given-names></name><name><surname>Volk</surname><given-names>D. W.</given-names></name><etal/></person-group>. (<year>2008</year>). <article-title>Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia</article-title>. <source>Mol. Psychiatry.</source>
<volume>13</volume>, <fpage>147</fpage>â<lpage>161</lpage>. <pub-id pub-id-type="doi">10.1038/sj.mp.4002011</pub-id><?supplied-pmid 17471287?><pub-id pub-id-type="pmid">17471287</pub-id></mixed-citation>
      </ref>
      <ref id="B38">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>Q.</given-names></name><name><surname>Nomura</surname><given-names>T.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Contractor</surname><given-names>A.</given-names></name></person-group> (<year>2014</year>). <article-title>The developmental switch in GABA polarity is delayed in fragile X mice</article-title>. <source>J. Neurosci.</source>
<volume>34</volume>, <fpage>446</fpage>â<lpage>450</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.4447-13.2014</pub-id><?supplied-pmid 24403144?><pub-id pub-id-type="pmid">24403144</pub-id></mixed-citation>
      </ref>
      <ref id="B39">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heinzen</surname><given-names>E. L.</given-names></name><name><surname>Radtke</surname><given-names>R. A.</given-names></name><name><surname>Urban</surname><given-names>T. J.</given-names></name><name><surname>Cavalleri</surname><given-names>G. L.</given-names></name><name><surname>Depondt</surname><given-names>C.</given-names></name><name><surname>Need</surname><given-names>A. C.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title>Rare deletions at 16p13.11 predispose to a diverse spectrum of sporadic epilepsy syndromes</article-title>. <source>Am. J. Hum .Genet.</source>
<volume>86</volume>, <fpage>707</fpage>â<lpage>718</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2010.03.018</pub-id><?supplied-pmid 20398883?><pub-id pub-id-type="pmid">20398883</pub-id></mixed-citation>
      </ref>
      <ref id="B40">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hekmat-Scafe</surname><given-names>D. S.</given-names></name><name><surname>Lundy</surname><given-names>M. Y.</given-names></name><name><surname>Ranga</surname><given-names>R.</given-names></name><name><surname>Tanouye</surname><given-names>M. A.</given-names></name></person-group> (<year>2006</year>). <article-title>Mutations in the K+/Cl- cotransporter gene kazachoc (kcc) increase seizure susceptibility in Drosophila</article-title>. <source>J. Neurosci.</source>
<volume>26</volume>, <fpage>8943</fpage>â<lpage>8954</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.4998-05.2006</pub-id><?supplied-pmid 16943550?><pub-id pub-id-type="pmid">16943550</pub-id></mixed-citation>
      </ref>
      <ref id="B41">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hekmat-Scafe</surname><given-names>D. S.</given-names></name><name><surname>Mercado</surname><given-names>A.</given-names></name><name><surname>Fajilan</surname><given-names>A. A.</given-names></name><name><surname>Lee</surname><given-names>A. W.</given-names></name><name><surname>Hsu</surname><given-names>R.</given-names></name><name><surname>Mount</surname><given-names>D. B.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title>Seizure sensitivity is ameliorated by targeted expression of K+-Cl- cotransporter function in the mushroom body of the Drosophila brain</article-title>. <source>Genetics.</source>
<volume>184</volume>, <fpage>171</fpage>â<lpage>183</lpage>. <pub-id pub-id-type="doi">10.1534/genetics.109.109074</pub-id><?supplied-pmid 19884312?><pub-id pub-id-type="pmid">19884312</pub-id></mixed-citation>
      </ref>
      <ref id="B42">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hubner</surname><given-names>C. A.</given-names></name><name><surname>Stein</surname><given-names>V.</given-names></name><name><surname>Hermans-Borgmeyer</surname><given-names>I.</given-names></name><name><surname>Meyer</surname><given-names>T.</given-names></name><name><surname>Ballanyi</surname><given-names>K.</given-names></name><name><surname>Jentsch</surname><given-names>T. J.</given-names></name></person-group> (<year>2001</year>). <article-title>Disruption of KCC2 reveals an essential role of K-Cl cotransport already in early synaptic inhibition</article-title>. <source>Neuron.</source>
<volume>30</volume>, <fpage>515</fpage>â<lpage>524</lpage>. <pub-id pub-id-type="doi">10.1016/s0896-6273(01)00297-5</pub-id><?supplied-pmid 11395011?><pub-id pub-id-type="pmid">11395011</pub-id></mixed-citation>
      </ref>
      <ref id="B43">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>International-Schizophrenia-Consortium</collab></person-group> (<year>2008</year>). <article-title>Rare chromosomal deletions and duplications increase risk of schizophrenia</article-title>. <source>Nature.</source>
<volume>455</volume>, <fpage>237</fpage>â<lpage>241</lpage>. <pub-id pub-id-type="doi">10.1038/nature07239</pub-id><?supplied-pmid 18668038?><pub-id pub-id-type="pmid">18668038</pub-id></mixed-citation>
      </ref>
      <ref id="B44">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iossifov</surname><given-names>I.</given-names></name><name><surname>Oâroak</surname><given-names>B. J.</given-names></name><name><surname>Sanders</surname><given-names>S. J.</given-names></name><name><surname>Ronemus</surname><given-names>M.</given-names></name><name><surname>Krumm</surname><given-names>N.</given-names></name><name><surname>Levy</surname><given-names>D.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>The contribution of de novo coding mutations to autism spectrum disorder</article-title>. <source>Nature.</source>
<volume>515</volume>, <fpage>216</fpage>â<lpage>221</lpage>. <pub-id pub-id-type="doi">10.1038/nature13908</pub-id><?supplied-pmid 25363768?><pub-id pub-id-type="pmid">25363768</pub-id></mixed-citation>
      </ref>
      <ref id="B45">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iossifov</surname><given-names>I.</given-names></name><name><surname>Ronemus</surname><given-names>M.</given-names></name><name><surname>Levy</surname><given-names>D.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Hakker</surname><given-names>I.</given-names></name><name><surname>Rosenbaum</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>2012</year>). <article-title>De novo gene disruptions in children on the autistic spectrum</article-title>. <source>Neuron.</source>
<volume>74</volume>, <fpage>285</fpage>â<lpage>299</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2012.04.009</pub-id><?supplied-pmid 22542183?><pub-id pub-id-type="pmid">22542183</pub-id></mixed-citation>
      </ref>
      <ref id="B46">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Irizarry</surname><given-names>R. A.</given-names></name><name><surname>Ladd-Acosta</surname><given-names>C.</given-names></name><name><surname>Wen</surname><given-names>B.</given-names></name><name><surname>Wu</surname><given-names>Z.</given-names></name><name><surname>Montano</surname><given-names>C.</given-names></name><name><surname>Onyango</surname><given-names>P.</given-names></name><etal/></person-group>. (<year>2009</year>). <article-title>The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores</article-title>. <source>Nat. Genet.</source>
<volume>41</volume>, <fpage>178</fpage>â<lpage>186</lpage>. <pub-id pub-id-type="doi">10.1038/ng.298</pub-id><?supplied-pmid 19151715?><pub-id pub-id-type="pmid">19151715</pub-id></mixed-citation>
      </ref>
      <ref id="B47">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kahle</surname><given-names>K. T.</given-names></name><name><surname>Deeb</surname><given-names>T. Z.</given-names></name><name><surname>Puskarjov</surname><given-names>M.</given-names></name><name><surname>Silayeva</surname><given-names>L.</given-names></name><name><surname>Liang</surname><given-names>B.</given-names></name><name><surname>Kaila</surname><given-names>K.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>Modulation of neuronal activity by phosphorylation of the K-Cl cotransporter KCC2</article-title>. <source>Trends Neurosci.</source>
<volume>36</volume>, <fpage>726</fpage>â<lpage>737</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2013.08.006</pub-id><?supplied-pmid 24139641?><pub-id pub-id-type="pmid">24139641</pub-id></mixed-citation>
      </ref>
      <ref id="B48">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kahle</surname><given-names>K. T.</given-names></name><name><surname>Merner</surname><given-names>N. D.</given-names></name><name><surname>Friedel</surname><given-names>P.</given-names></name><name><surname>Silayeva</surname><given-names>L.</given-names></name><name><surname>Liang</surname><given-names>B.</given-names></name><name><surname>Khanna</surname><given-names>A.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Genetically encoded impairment of neuronal KCC2 cotransporter function in human idiopathic generalized epilepsy</article-title>. <source>EMBO Rep.</source>
<volume>15</volume>, <fpage>766</fpage>â<lpage>774</lpage>. <pub-id pub-id-type="doi">10.15252/embr.201438840</pub-id><?supplied-pmid 24928908?><pub-id pub-id-type="pmid">24928908</pub-id></mixed-citation>
      </ref>
      <ref id="B49">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaila</surname><given-names>K.</given-names></name><name><surname>Price</surname><given-names>T. J.</given-names></name><name><surname>Payne</surname><given-names>J. A.</given-names></name><name><surname>Puskarjov</surname><given-names>M.</given-names></name><name><surname>Voipio</surname><given-names>J.</given-names></name></person-group> (<year>2014</year>). <article-title>Cation-chloride cotransporters in neuronal development, plasticity and disease</article-title>. <source>Nat. Rev. Neurosci.</source>
<volume>15</volume>, <fpage>637</fpage>â<lpage>654</lpage>. <pub-id pub-id-type="doi">10.1038/nrn3819</pub-id><?supplied-pmid 25234263?><pub-id pub-id-type="pmid">25234263</pub-id></mixed-citation>
      </ref>
      <ref id="B50">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalanithi</surname><given-names>P. S. A.</given-names></name><name><surname>Zheng</surname><given-names>W.</given-names></name><name><surname>Kataoka</surname><given-names>Y.</given-names></name><name><surname>Difiglia</surname><given-names>M.</given-names></name><name><surname>Grantz</surname><given-names>H.</given-names></name><name><surname>Saper</surname><given-names>C. B.</given-names></name><etal/></person-group>. (<year>2005</year>). <article-title>Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome</article-title>. <source>Proc. Natl. Acad. Sci. U S A</source>
<volume>102</volume>, <fpage>13307</fpage>â<lpage>13312</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0502624102</pub-id><?supplied-pmid 16131542?><pub-id pub-id-type="pmid">16131542</pub-id></mixed-citation>
      </ref>
      <ref id="B51">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>J. Q.</given-names></name><name><surname>Macdonald</surname><given-names>R. L.</given-names></name></person-group> (<year>2009</year>). <article-title>Making sense of nonsense GABA(A) receptor mutations associated with genetic epilepsies</article-title>. <source>Trends Mol. Med.</source>
<volume>15</volume>, <fpage>430</fpage>â<lpage>438</lpage>. <pub-id pub-id-type="doi">10.1016/j.molmed.2009.07.003</pub-id><?supplied-pmid 19717338?><pub-id pub-id-type="pmid">19717338</pub-id></mixed-citation>
      </ref>
      <ref id="B52">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiezun</surname><given-names>A.</given-names></name><name><surname>Garimella</surname><given-names>K.</given-names></name><name><surname>Do</surname><given-names>R.</given-names></name><name><surname>Stitziel</surname><given-names>N. O.</given-names></name><name><surname>Neale</surname><given-names>B. M.</given-names></name><name><surname>Mclaren</surname><given-names>P. J.</given-names></name><etal/></person-group>. (<year>2012</year>). <article-title>Exome sequencing and the genetic basis of complex traits</article-title>. <source>Nat. Genet.</source>
<volume>44</volume>, <fpage>623</fpage>â<lpage>630</lpage>. <pub-id pub-id-type="doi">10.1038/ng.2303</pub-id><?supplied-pmid 22641211?><pub-id pub-id-type="pmid">22641211</pub-id></mixed-citation>
      </ref>
      <ref id="B53">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirov</surname><given-names>G.</given-names></name><name><surname>Grozeva</surname><given-names>D.</given-names></name><name><surname>Norton</surname><given-names>N.</given-names></name><name><surname>Ivanov</surname><given-names>D.</given-names></name><name><surname>Mantripragada</surname><given-names>K. K.</given-names></name><name><surname>Holmans</surname><given-names>P.</given-names></name><etal/></person-group>. (<year>2009</year>). <article-title>Support for the involvement of large copy number variants in the pathogenesis of schizophrenia</article-title>. <source>Hum. Mol. Genet.</source>
<volume>18</volume>, <fpage>1497</fpage>â<lpage>1503</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddp043</pub-id><?supplied-pmid 19181681?><pub-id pub-id-type="pmid">19181681</pub-id></mixed-citation>
      </ref>
      <ref id="B54">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klassen</surname><given-names>T.</given-names></name><name><surname>Davis</surname><given-names>C.</given-names></name><name><surname>Goldman</surname><given-names>A.</given-names></name><name><surname>Burgess</surname><given-names>D.</given-names></name><name><surname>Chen</surname><given-names>T.</given-names></name><name><surname>Wheeler</surname><given-names>D.</given-names></name><etal/></person-group>. (<year>2011</year>). <article-title>Exome sequencing of ion channel genes reveals complex profiles confounding personal risk assessment in epilepsy</article-title>. <source>Cell.</source>
<volume>145</volume>, <fpage>1036</fpage>â<lpage>1048</lpage>. <pub-id pub-id-type="doi">10.3410/f.12207957.13373055</pub-id><?supplied-pmid 21703448?><pub-id pub-id-type="pmid">21703448</pub-id></mixed-citation>
      </ref>
      <ref id="B55">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krumm</surname><given-names>N.</given-names></name><name><surname>Oâroak</surname><given-names>B. J.</given-names></name><name><surname>Shendure</surname><given-names>J.</given-names></name><name><surname>Eichler</surname><given-names>E. E.</given-names></name></person-group> (<year>2014</year>). <article-title>A de novo convergence of autism genetics and molecular neuroscience</article-title>. <source>Trends Neurosci.</source>
<volume>37</volume>, <fpage>95</fpage>â<lpage>105</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2013.11.005</pub-id><?supplied-pmid 24387789?><pub-id pub-id-type="pmid">24387789</pub-id></mixed-citation>
      </ref>
      <ref id="B56">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krystal</surname><given-names>J. H.</given-names></name><name><surname>State</surname><given-names>M. W.</given-names></name></person-group> (<year>2014</year>). <article-title>Psychiatric disorders: diagnosis to therapy</article-title>. <source>Cell.</source>
<volume>157</volume>, <fpage>201</fpage>â<lpage>214</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2014.02.042</pub-id><?supplied-pmid 24679536?><pub-id pub-id-type="pmid">24679536</pub-id></mixed-citation>
      </ref>
      <ref id="B57">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kryukov</surname><given-names>G. V.</given-names></name><name><surname>Shpunt</surname><given-names>A.</given-names></name><name><surname>Stamatoyannopoulos</surname><given-names>J. A.</given-names></name><name><surname>Sunyaev</surname><given-names>S. R.</given-names></name></person-group> (<year>2009</year>). <article-title>Power of deep, all-exon resequencing for discovery of human trait genes</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source>
<volume>106</volume>, <fpage>3871</fpage>â<lpage>3876</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0812824106</pub-id><?supplied-pmid 19202052?><pub-id pub-id-type="pmid">19202052</pub-id></mixed-citation>
      </ref>
      <ref id="B58">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lam</surname><given-names>C. W.</given-names></name><name><surname>Yeung</surname><given-names>W. L.</given-names></name><name><surname>Ko</surname><given-names>C. H.</given-names></name><name><surname>Poon</surname><given-names>P. M.</given-names></name><name><surname>Tong</surname><given-names>S. F.</given-names></name><name><surname>Chan</surname><given-names>K. Y.</given-names></name><etal/></person-group>. (<year>2000</year>). <article-title>Spectrum of mutations in the MECP2 gene in patients with infantile autism and Rett syndrome</article-title>. <source>J. Med. Genet.</source>
<volume>37</volume>:<fpage>E41</fpage>. <pub-id pub-id-type="doi">10.1136/jmg.37.12.e41</pub-id><?supplied-pmid 11106359?><pub-id pub-id-type="pmid">11106359</pub-id></mixed-citation>
      </ref>
      <ref id="B59">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larkin</surname><given-names>M. A.</given-names></name><name><surname>Blackshields</surname><given-names>G.</given-names></name><name><surname>Brown</surname><given-names>N. P.</given-names></name><name><surname>Chenna</surname><given-names>R.</given-names></name><name><surname>Mcgettigan</surname><given-names>P. A.</given-names></name><name><surname>Mcwilliam</surname><given-names>H.</given-names></name><etal/></person-group>. (<year>2007</year>). <article-title>Clustal W and Clustal X version 2.0</article-title>. <source>Bioinformatics.</source>
<volume>23</volume>, <fpage>2947</fpage>â<lpage>2948</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btm404</pub-id><?supplied-pmid 17846036?><pub-id pub-id-type="pmid">17846036</pub-id></mixed-citation>
      </ref>
      <ref id="B60">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lemonnier</surname><given-names>E.</given-names></name><name><surname>Degrez</surname><given-names>C.</given-names></name><name><surname>Phelep</surname><given-names>M.</given-names></name><name><surname>Tyzio</surname><given-names>R.</given-names></name><name><surname>Josse</surname><given-names>F.</given-names></name><name><surname>Grandgeorge</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2012</year>). <article-title>A randomised controlled trial of bumetanide in the treatment of autism in children</article-title>. <source>Transl. Psychiatry.</source>
<volume>2</volume>:<fpage>e197</fpage>. <pub-id pub-id-type="doi">10.1038/tp.2012.124</pub-id><?supplied-pmid 23233021?><pub-id pub-id-type="pmid">23233021</pub-id></mixed-citation>
      </ref>
      <ref id="B61">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lemonnier</surname><given-names>E.</given-names></name><name><surname>Robin</surname><given-names>G.</given-names></name><name><surname>Degrez</surname><given-names>C.</given-names></name><name><surname>Tyzio</surname><given-names>R.</given-names></name><name><surname>Grandgeorge</surname><given-names>M.</given-names></name><name><surname>Ben-Ari</surname><given-names>Y.</given-names></name></person-group> (<year>2013</year>). <article-title>Treating Fragile X syndrome with the diuretic bumetanide: a case report</article-title>. <source>Acta. Paediatrica.</source>
<volume>102</volume>, <fpage>e288</fpage>â<lpage>e290</lpage>. <pub-id pub-id-type="doi">10.1111/apa.12235</pub-id><?supplied-pmid 23647528?><pub-id pub-id-type="pmid">23647528</pub-id></mixed-citation>
      </ref>
      <ref id="B62">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>D. A.</given-names></name><name><surname>Curley</surname><given-names>A. A.</given-names></name><name><surname>Glausier</surname><given-names>J. R.</given-names></name><name><surname>Volk</surname><given-names>D. W.</given-names></name></person-group> (<year>2012</year>). <article-title>Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia</article-title>. <source>Trends Neurosci.</source>
<volume>35</volume>, <fpage>57</fpage>â<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2011.10.004</pub-id><?supplied-pmid 22154068?><pub-id pub-id-type="pmid">22154068</pub-id></mixed-citation>
      </ref>
      <ref id="B63">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Medina</surname><given-names>I.</given-names></name><name><surname>Friedel</surname><given-names>P.</given-names></name><name><surname>Rivera</surname><given-names>C.</given-names></name><name><surname>Kahle</surname><given-names>K. T.</given-names></name><name><surname>Kourdougli</surname><given-names>N.</given-names></name><name><surname>Uvarov</surname><given-names>P.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Current view on the functional regulation of the neuronal K<sup>+</sup>-Cl<sup>â</sup> cotransporter KCC2</article-title>. <source>Front. Cell. Neurosci.</source>
<volume>8</volume>:<fpage>27</fpage>. <pub-id pub-id-type="doi">10.3389/fncel.2014.00027</pub-id><?supplied-pmid 24567703?><pub-id pub-id-type="pmid">24567703</pub-id></mixed-citation>
      </ref>
      <ref id="B64">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Medrihan</surname><given-names>L.</given-names></name><name><surname>Tantalaki</surname><given-names>E.</given-names></name><name><surname>Aramuni</surname><given-names>G.</given-names></name><name><surname>Sargsyan</surname><given-names>V.</given-names></name><name><surname>Dudanova</surname><given-names>I.</given-names></name><name><surname>Missler</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2008</year>). <article-title>Early defects of GABAergic synapses in the brain stem of a MeCP2 mouse model of Rett syndrome</article-title>. <source>J. Neurophysiol.</source>
<volume>99</volume>, <fpage>112</fpage>â<lpage>121</lpage>. <pub-id pub-id-type="doi">10.1152/jn.00826.2007</pub-id><?supplied-pmid 18032561?><pub-id pub-id-type="pmid">18032561</pub-id></mixed-citation>
      </ref>
      <ref id="B65">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mefford</surname><given-names>H. C.</given-names></name><name><surname>Cooper</surname><given-names>G. M.</given-names></name><name><surname>Zerr</surname><given-names>T.</given-names></name><name><surname>Smith</surname><given-names>J. D.</given-names></name><name><surname>Baker</surname><given-names>C.</given-names></name><name><surname>Shafer</surname><given-names>N.</given-names></name><etal/></person-group>. (<year>2009</year>). <article-title>A method for rapid, targeted CNV genotyping identifies rare variants associated with neurocognitive disease</article-title>. <source>Genome. Res.</source>
<volume>19</volume>, <fpage>1579</fpage>â<lpage>1585</lpage>. <pub-id pub-id-type="doi">10.1101/gr.094987.109</pub-id><?supplied-pmid 19506092?><pub-id pub-id-type="pmid">19506092</pub-id></mixed-citation>
      </ref>
      <ref id="B66">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mefford</surname><given-names>H. C.</given-names></name><name><surname>Sharp</surname><given-names>A. J.</given-names></name><name><surname>Baker</surname><given-names>C.</given-names></name><name><surname>Itsara</surname><given-names>A.</given-names></name><name><surname>Jiang</surname><given-names>Z.</given-names></name><name><surname>Buysse</surname><given-names>K.</given-names></name><etal/></person-group>. (<year>2008</year>). <article-title>Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes</article-title>. <source>N. Engl. J. Med.</source>
<volume>359</volume>, <fpage>1685</fpage>â<lpage>1699</lpage>. <pub-id pub-id-type="doi">10.1056/nejmoa0805384</pub-id><?supplied-pmid 18784092?><pub-id pub-id-type="pmid">18784092</pub-id></mixed-citation>
      </ref>
      <ref id="B67">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mi</surname><given-names>H.</given-names></name><name><surname>Lazareva-Ulitsky</surname><given-names>B.</given-names></name><name><surname>Loo</surname><given-names>R.</given-names></name><name><surname>Kejariwal</surname><given-names>A.</given-names></name><name><surname>Vandergriff</surname><given-names>J.</given-names></name><name><surname>Rabkin</surname><given-names>S.</given-names></name><etal/></person-group>. (<year>2005</year>). <article-title>The PANTHER database of protein families, subfamilies, functions and pathways</article-title>. <source>Nucleic. Acids. Res.</source>
<volume>33</volume>, <fpage>D284</fpage>â<lpage>288</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gki078</pub-id><?supplied-pmid 15608197?><pub-id pub-id-type="pmid">15608197</pub-id></mixed-citation>
      </ref>
      <ref id="B68">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>K. J.</given-names></name></person-group> (<year>2011</year>). <article-title>The genetics of neurodevelopmental disease</article-title>. <source>Curr Opin Neurobiol.</source>
<volume>21</volume>, <fpage>197</fpage>â<lpage>203</lpage>. <pub-id pub-id-type="doi">10.1002/9781118524947</pub-id><?supplied-pmid 20832285?><pub-id pub-id-type="pmid">20832285</pub-id></mixed-citation>
      </ref>
      <ref id="B69">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neale</surname><given-names>B. M.</given-names></name><name><surname>Kou</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Maâayan</surname><given-names>A.</given-names></name><name><surname>Samocha</surname><given-names>K. E.</given-names></name><name><surname>Sabo</surname><given-names>A.</given-names></name><etal/></person-group>. (<year>2012</year>). <article-title>Patterns and rates of exonic de novo mutations in autism spectrum disorders</article-title>. <source>Nature.</source>
<volume>485</volume>, <fpage>242</fpage>â<lpage>245</lpage>. <pub-id pub-id-type="doi">10.1038/nature11011</pub-id><?supplied-pmid 22495311?><pub-id pub-id-type="pmid">22495311</pub-id></mixed-citation>
      </ref>
      <ref id="B70">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>OâRoak</surname><given-names>B. J.</given-names></name><name><surname>Deriziotis</surname><given-names>P.</given-names></name><name><surname>Lee</surname><given-names>C.</given-names></name><name><surname>Vives</surname><given-names>L.</given-names></name><name><surname>Schwartz</surname><given-names>J. J.</given-names></name><name><surname>Girirajan</surname><given-names>S.</given-names></name><etal/></person-group>. (<year>2011</year>). <article-title>Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations</article-title>. <source>Nat. Genet.</source>
<volume>43</volume>, <fpage>585</fpage>â<lpage>589</lpage>. <pub-id pub-id-type="doi">10.3410/f.10819956.11732055</pub-id><?supplied-pmid 21572417?><pub-id pub-id-type="pmid">21572417</pub-id></mixed-citation>
      </ref>
      <ref id="B71">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>OâRoak</surname><given-names>B. J.</given-names></name><name><surname>Vives</surname><given-names>L.</given-names></name><name><surname>Girirajan</surname><given-names>S.</given-names></name><name><surname>Karakoc</surname><given-names>E.</given-names></name><name><surname>Krumm</surname><given-names>N.</given-names></name><name><surname>Coe</surname><given-names>B. P.</given-names></name><etal/></person-group>. (<year>2012</year>). <article-title>Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations</article-title>. <source>Nature.</source>
<volume>485</volume>, <fpage>246</fpage>â<lpage>250</lpage>. <pub-id pub-id-type="doi">10.3410/f.716397823.791302874</pub-id><?supplied-pmid 22495309?><pub-id pub-id-type="pmid">22495309</pub-id></mixed-citation>
      </ref>
      <ref id="B72">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pescosolido</surname><given-names>M. F.</given-names></name><name><surname>Yang</surname><given-names>U.</given-names></name><name><surname>Sabbagh</surname><given-names>M.</given-names></name><name><surname>Morrow</surname><given-names>E. M.</given-names></name></person-group> (<year>2012</year>). <article-title>Lighting a path: genetic studies pinpoint neurodevelopmental mechanisms in autism and related disorders</article-title>. <source>Dialogues Clin. Neurosci.</source>
<volume>14</volume>, <fpage>239</fpage>â<lpage>252</lpage>. <?supplied-pmid 23226950?><pub-id pub-id-type="pmid">23226950</pub-id></mixed-citation>
      </ref>
      <ref id="B73">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Purcell</surname><given-names>S.</given-names></name><name><surname>Cherny</surname><given-names>S. S.</given-names></name><name><surname>Sham</surname><given-names>P. C.</given-names></name></person-group> (<year>2003</year>). <article-title>Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits</article-title>. <source>Bioinformatics.</source>
<volume>19</volume>, <fpage>149</fpage>â<lpage>150</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/19.1.149</pub-id><?supplied-pmid 12499305?><pub-id pub-id-type="pmid">12499305</pub-id></mixed-citation>
      </ref>
      <ref id="B74">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Purcell</surname><given-names>S. M.</given-names></name><name><surname>Moran</surname><given-names>J. L.</given-names></name><name><surname>Fromer</surname><given-names>M.</given-names></name><name><surname>Ruderfer</surname><given-names>D.</given-names></name><name><surname>Solovieff</surname><given-names>N.</given-names></name><name><surname>Roussos</surname><given-names>P.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>A polygenic burden of rare disruptive mutations in schizophrenia</article-title>. <source>Nature.</source>
<volume>506</volume>, <fpage>185</fpage>â<lpage>190</lpage>. <pub-id pub-id-type="doi">10.1038/nature12975</pub-id><?supplied-pmid 24463508?><pub-id pub-id-type="pmid">24463508</pub-id></mixed-citation>
      </ref>
      <ref id="B75">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puskarjov</surname><given-names>M.</given-names></name><name><surname>Seja</surname><given-names>P.</given-names></name><name><surname>Heron</surname><given-names>S. E.</given-names></name><name><surname>Williams</surname><given-names>T. C.</given-names></name><name><surname>Ahmad</surname><given-names>F.</given-names></name><name><surname>Iona</surname><given-names>X.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>A variant of KCC2 from patients with febrile seizures impairs neuronal Cl- extrusion and dendritic spine formation</article-title>. <source>EMBO Rep.</source>
<volume>15</volume>, <fpage>723</fpage>â<lpage>729</lpage>. <pub-id pub-id-type="doi">10.1002/embr.201438749</pub-id><?supplied-pmid 24668262?><pub-id pub-id-type="pmid">24668262</pub-id></mixed-citation>
      </ref>
      <ref id="B76">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roy</surname><given-names>A.</given-names></name><name><surname>Kucukural</surname><given-names>A.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name></person-group> (<year>2010</year>). <article-title>I-TASSER: a unified platform for automated protein structure and function prediction</article-title>. <source>Nat Protoc.</source>
<volume>5</volume>, <fpage>725</fpage>â<lpage>738</lpage>. <pub-id pub-id-type="doi">10.1038/nprot.2010.5</pub-id><pub-id pub-id-type="pmid">20360767</pub-id></mixed-citation>
      </ref>
      <ref id="B77">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rubenstein</surname><given-names>J. L. R.</given-names></name></person-group> (<year>2011</year>). <article-title>Annual Research Review: Development of the cerebral cortex: implications for neurodevelopmental disorders</article-title>. <source>J. Child. Psychol. Psychiatry.</source>
<volume>52</volume>, <fpage>339</fpage>â<lpage>355</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-7610.2010.02307</pub-id><?supplied-pmid 20735793?><pub-id pub-id-type="pmid">20735793</pub-id></mixed-citation>
      </ref>
      <ref id="B78">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salomons</surname><given-names>G. S.</given-names></name><name><surname>Van Dooren</surname><given-names>S. J.</given-names></name><name><surname>Verhoeven</surname><given-names>N. M.</given-names></name><name><surname>Cecil</surname><given-names>K. M.</given-names></name><name><surname>Ball</surname><given-names>W. S.</given-names></name><name><surname>Degrauw</surname><given-names>T. J.</given-names></name><etal/></person-group>. (<year>2001</year>). <article-title>X-linked creatine-transporter gene (SLC6A8) defect: a new creatine-deficiency syndrome</article-title>. <source>Am. J. Hum .Genet.</source>
<volume>68</volume>, <fpage>1497</fpage>â<lpage>1500</lpage>. <pub-id pub-id-type="doi">10.1086/320595</pub-id><?supplied-pmid 11326334?><pub-id pub-id-type="pmid">11326334</pub-id></mixed-citation>
      </ref>
      <ref id="B79">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanders</surname><given-names>S. J.</given-names></name><name><surname>Murtha</surname><given-names>M. T.</given-names></name><name><surname>Gupta</surname><given-names>A. R.</given-names></name><name><surname>Murdoch</surname><given-names>J. D.</given-names></name><name><surname>Raubeson</surname><given-names>M. J.</given-names></name><name><surname>Willsey</surname><given-names>A. J.</given-names></name><etal/></person-group>. (<year>2012</year>). <article-title>De novo mutations revealed by whole-exome sequencing are strongly associated with autism</article-title>. <source>Nature.</source>
<volume>485</volume>, <fpage>237</fpage>â<lpage>241</lpage>. <pub-id pub-id-type="doi">10.1038/nature10945</pub-id><?supplied-pmid 22495306?><pub-id pub-id-type="pmid">22495306</pub-id></mixed-citation>
      </ref>
      <ref id="B80">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>M. J.</given-names></name><name><surname>Mirnics</surname><given-names>K.</given-names></name></person-group> (<year>2014</year>). <article-title>Neurodevelopment, GABA System Dysfunction and Schizophrenia</article-title>. <source>Neuropsychopharmacology.</source>
<volume>40</volume>, <fpage>190</fpage>â<lpage>206</lpage>. <pub-id pub-id-type="doi">10.1038/npp.2014.95</pub-id><?supplied-pmid 24759129?><pub-id pub-id-type="pmid">24759129</pub-id></mixed-citation>
      </ref>
      <ref id="B81">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwarz</surname><given-names>J. M.</given-names></name><name><surname>Rodelsperger</surname><given-names>C.</given-names></name><name><surname>Schuelke</surname><given-names>M.</given-names></name><name><surname>Seelow</surname><given-names>D.</given-names></name></person-group> (<year>2010</year>). <article-title>MutationTaster evaluates disease-causing potential of sequence alterations</article-title>. <source>Nat. Methods.</source>
<volume>7</volume>, <fpage>575</fpage>â<lpage>576</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth0810-575</pub-id><?supplied-pmid 20676075?><pub-id pub-id-type="pmid">20676075</pub-id></mixed-citation>
      </ref>
      <ref id="B82">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stefansson</surname><given-names>H.</given-names></name><name><surname>Rujescu</surname><given-names>D.</given-names></name><name><surname>Cichon</surname><given-names>S.</given-names></name><name><surname>Pietilainen</surname><given-names>O. P.</given-names></name><name><surname>Ingason</surname><given-names>A.</given-names></name><name><surname>Steinberg</surname><given-names>S.</given-names></name><etal/></person-group>. (<year>2008</year>). <article-title>Large recurrent microdeletions associated with schizophrenia</article-title>. <source>Nature.</source>
<volume>455</volume>, <fpage>232</fpage>â<lpage>236</lpage>. <pub-id pub-id-type="doi">10.1038/nature07229</pub-id><?supplied-pmid 18668039?><pub-id pub-id-type="pmid">18668039</pub-id></mixed-citation>
      </ref>
      <ref id="B83">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Talos</surname><given-names>D. M.</given-names></name><name><surname>Sun</surname><given-names>H.</given-names></name><name><surname>Kosaras</surname><given-names>B.</given-names></name><name><surname>Joseph</surname><given-names>A.</given-names></name><name><surname>Folkerth</surname><given-names>R. D.</given-names></name><name><surname>Poduri</surname><given-names>A.</given-names></name><etal/></person-group>. (<year>2012</year>). <article-title>Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia</article-title>. <source>Ann. Neurol.</source>
<volume>71</volume>, <fpage>539</fpage>â<lpage>551</lpage>. <pub-id pub-id-type="doi">10.1002/ana.22696</pub-id><?supplied-pmid 22447678?><pub-id pub-id-type="pmid">22447678</pub-id></mixed-citation>
      </ref>
      <ref id="B84">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanis</surname><given-names>J. E.</given-names></name><name><surname>Bellemer</surname><given-names>A.</given-names></name><name><surname>Moresco</surname><given-names>J. J.</given-names></name><name><surname>Forbush</surname><given-names>B.</given-names></name><name><surname>Koelle</surname><given-names>M. R.</given-names></name></person-group> (<year>2009</year>). <article-title>The potassium chloride cotransporter KCC-2 coordinates development of inhibitory neurotransmission and synapse structure in Caenorhabditis elegans</article-title>. <source>J. Neurosci.</source>
<volume>29</volume>, <fpage>9943</fpage>â<lpage>9954</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.1989-09.2009</pub-id><?supplied-pmid 19675228?><pub-id pub-id-type="pmid">19675228</pub-id></mixed-citation>
      </ref>
      <ref id="B85">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tornberg</surname><given-names>J.</given-names></name><name><surname>Voikar</surname><given-names>V.</given-names></name><name><surname>Savilahti</surname><given-names>H.</given-names></name><name><surname>Rauvala</surname><given-names>H.</given-names></name><name><surname>Airaksinen</surname><given-names>M. S.</given-names></name></person-group> (<year>2005</year>). <article-title>Behavioural phenotypes of hypomorphic KCC2-deficient mice</article-title>. <source>Eur. J. Neurosci.</source>
<volume>21</volume>, <fpage>1327</fpage>â<lpage>1337</lpage>. <pub-id pub-id-type="doi">10.1111/j.1460-9568.2005.03959.x</pub-id><?supplied-pmid 15813942?><pub-id pub-id-type="pmid">15813942</pub-id></mixed-citation>
      </ref>
      <ref id="B86">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tuchman</surname><given-names>R.</given-names></name><name><surname>Rapin</surname><given-names>I.</given-names></name></person-group> (<year>2002</year>). <article-title>Epilepsy in autism</article-title>. <source>Lancet Neurol.</source>
<volume>1</volume>, <fpage>352</fpage>â<lpage>358</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-4614-0361-6_24</pub-id><?supplied-pmid 12849396?><pub-id pub-id-type="pmid">12849396</pub-id></mixed-citation>
      </ref>
      <ref id="B87">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tyzio</surname><given-names>R.</given-names></name><name><surname>Nardou</surname><given-names>R.</given-names></name><name><surname>Ferrari</surname><given-names>D. C.</given-names></name><name><surname>Tsintsadze</surname><given-names>T.</given-names></name><name><surname>Shahrokhi</surname><given-names>A.</given-names></name><name><surname>Eftekhari</surname><given-names>S.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Oxytocin-Mediated GABA Inhibition During Delivery Attenuates Autism Pathogenesis in Rodent Offspring</article-title>. <source>Science.</source>
<volume>343</volume>, <fpage>675</fpage>â<lpage>679</lpage>. <pub-id pub-id-type="doi">10.1126/science.1247190</pub-id><?supplied-pmid 24503856?><pub-id pub-id-type="pmid">24503856</pub-id></mixed-citation>
      </ref>
      <ref id="B88">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ullmann</surname><given-names>R.</given-names></name><name><surname>Turner</surname><given-names>G.</given-names></name><name><surname>Kirchhoff</surname><given-names>M.</given-names></name><name><surname>Chen</surname><given-names>W.</given-names></name><name><surname>Tonge</surname><given-names>B.</given-names></name><name><surname>Rosenberg</surname><given-names>C.</given-names></name><etal/></person-group>. (<year>2007</year>). <article-title>Array CGH identifies reciprocal 16p13.1 duplications and deletions that predispose to autism and/or mental retardation</article-title>. <source>Hum. Mutat.</source>
<volume>28</volume>, <fpage>674</fpage>â<lpage>682</lpage>. <pub-id pub-id-type="doi">10.1002/humu.20546</pub-id><?supplied-pmid 26385973?><pub-id pub-id-type="pmid">17480035</pub-id></mixed-citation>
      </ref>
      <ref id="B89">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vissers</surname><given-names>L. E.</given-names></name><name><surname>De Ligt</surname><given-names>J.</given-names></name><name><surname>Gilissen</surname><given-names>C.</given-names></name><name><surname>Janssen</surname><given-names>I.</given-names></name><name><surname>Steehouwer</surname><given-names>M.</given-names></name><name><surname>De Vries</surname><given-names>P.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title>A de novo paradigm for mental retardation</article-title>. <source>Nat. Genet.</source>
<volume>42</volume>, <fpage>1109</fpage>â<lpage>1112</lpage>. <pub-id pub-id-type="doi">10.1038/ng.712</pub-id><?supplied-pmid 21076407?><pub-id pub-id-type="pmid">21076407</pub-id></mixed-citation>
      </ref>
      <ref id="B90">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Voineagu</surname><given-names>I.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Johnston</surname><given-names>P.</given-names></name><name><surname>Lowe</surname><given-names>J. K.</given-names></name><name><surname>Tian</surname><given-names>Y.</given-names></name><name><surname>Horvath</surname><given-names>S.</given-names></name><etal/></person-group>. (<year>2011</year>). <article-title>Transcriptomic analysis of autistic brain reveals convergent molecular pathology</article-title>. <source>Nature.</source>
<volume>474</volume>, <fpage>380</fpage>â<lpage>384</lpage>. <pub-id pub-id-type="doi">10.1038/nature10110</pub-id><?supplied-pmid 21614001?><pub-id pub-id-type="pmid">21614001</pub-id></mixed-citation>
      </ref>
      <ref id="B91">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woo</surname><given-names>N. S.</given-names></name><name><surname>Lu</surname><given-names>J.</given-names></name><name><surname>England</surname><given-names>R.</given-names></name><name><surname>Mcclellan</surname><given-names>R.</given-names></name><name><surname>Dufour</surname><given-names>S.</given-names></name><name><surname>Mount</surname><given-names>D. B.</given-names></name><etal/></person-group>. (<year>2002</year>). <article-title>Hyperexcitability and epilepsy associated with disruption of the mouse neuronal-specific K-Cl cotransporter gene</article-title>. <source>Hippocampus.</source>
<volume>12</volume>, <fpage>258</fpage>â<lpage>268</lpage>. <pub-id pub-id-type="doi">10.1002/hipo.10014</pub-id><?supplied-pmid 12000122?><pub-id pub-id-type="pmid">12000122</pub-id></mixed-citation>
      </ref>
      <ref id="B92">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>B.</given-names></name><name><surname>Roos</surname><given-names>J. L.</given-names></name><name><surname>Dexheimer</surname><given-names>P.</given-names></name><name><surname>Boone</surname><given-names>B.</given-names></name><name><surname>Plummer</surname><given-names>B.</given-names></name><name><surname>Levy</surname><given-names>S.</given-names></name><etal/></person-group>. (<year>2011</year>). <article-title>Exome sequencing supports a de novo mutational paradigm for schizophrenia</article-title>. <source>Nat. Genet.</source>
<volume>43</volume>, <fpage>864</fpage>â<lpage>868</lpage>. <pub-id pub-id-type="doi">10.1038/ng.902</pub-id><?supplied-pmid 21822266?><pub-id pub-id-type="pmid">21822266</pub-id></mixed-citation>
      </ref>
      <ref id="B93">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>L.</given-names></name><name><surname>Polley</surname><given-names>N.</given-names></name><name><surname>Mathews</surname><given-names>G. C.</given-names></name><name><surname>Delpire</surname><given-names>E.</given-names></name></person-group> (<year>2008</year>). <article-title>NKCC1 and KCC2 prevent hyperexcitability in the mouse hippocampus</article-title>. <source>Epilepsy Res.</source>
<volume>79</volume>, <fpage>201</fpage>â<lpage>212</lpage>. <pub-id pub-id-type="doi">10.1016/j.eplepsyres.2008.02.005</pub-id><?supplied-pmid 18394864?><pub-id pub-id-type="pmid">18394864</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>